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Abstract 
 
Cardiovascular diseases and cancer are the top two leading causes of death in the United 
States according to the U.S. department of health and human services. Fast growing technologies 
are being developed to early diagnose and/or treat both heart diseases and cancers. One of the most 
successful cardiovascular devices is the cardiac pacemaker. Although cardiac pacemakers have 
been used by millions of patients worldwide, these pacemakers still suffer from several limitations 
because of the power source. Like other electronic devices that rely on batteries for their power, 
cardiac pacemakers must be replaced when the battery is drained. In addition, batteries electrode 
materials and electrolytes are toxic which raise serious safety concerns if leakage happen inside 
the patient’s body. In addition to their toxicity, these batteries represent more than 50-70 % of the 
size of implantable pacemakers which limits further miniaturization. In addition, portable 
electrochemical biosensors require durable portable power source to drive their electrochemical 
reaction and obtain the detection signal.  
In this thesis, biosupercapacitors were first developed as thin, safe, light-weight, low-cost, 
and durable power sources for the next generation of miniaturized implantable biomedical devices 
and portable disease biosensors. Moreover, additive manufacturing techniques such as 3-D 
printing, and screen printing were used to fabricate the different components of the portable 
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electrochemical biosensors designed for cancer biomarker detection as well as DNA damage 
screening assays. Finally, novel triboelectric nanogenerator devices were developed and used as a 
sensor/energy harvester systems for biomedical, mechanical, and soft robotics applications. 
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CHAPTER 1 
 
Introduction 
 
1-1. Goals and Significance 
 
Cardiovascular diseases and cancer are the top two leading causes of death in the United 
States according to the U.S. department of health and human services. Fast growing technologies 
are being developed to early diagnose and/or treat cancer and heart diseases. From one hand, 
implantable biomedical devices such as cardiac pacemakers have saved millions of lives by 
monitoring and regulating the patient’s heart rhythm.1 These pacemakers still suffer from several 
limitations because of the power source.2 Like other electronic devices that rely on batteries for 
their power, cardiac pacemakers must be replaced when the battery is drained. In addition, batteries 
electrode materials and electrolytes are toxic which raise serious safety concerns if leakage happen 
inside the patient’s body. In addition to their toxicity, these batteries represent more than 50-75% 
of the size of implantable bioelectronics which limits further miniaturization.5  
Furthermore, the integration of implantable energy harvesters with energy storage devices 
may enable a new generation of pacemakers that can run for a lifetime without the need for a 
battery.5 Self-powered bioelectronics have also shown great promise for nerve stimulation and 
wearable electronics which may lead to new techniques for the regeneration of damaged axons, 
something that will have a great impact on the future of medicine.6 Therefore, thin, safe and 
durable power sources are required for the next generation of miniaturized and self-powered 
biomedical devices.  
One goal of this research is to introduce the concept of self-powered biosupercapacitors as 
an ultrathin, and non-toxic for the next generation of implantable pacemakers. Chapter 2 addresses 
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the drawbacks of the existing pacemakers power sources, the requirement of the new effective 
alternative, the first biosupercapacitor prototype, and it’s full characterization and performance in 
cell culture media.  
On the other hand, reliable bioanalytical devices capable detecting diseases and DNA 
damage are critical for early diagnosis and the drug discovery process.7 For example, feasible early 
detection is currently the best hope for successful cancer patient outcomes.8 Measuring protein 
biomarkers overexpressed into blood due to cancer has great early diagnostic potential,9 that is still 
largely untapped in the clinic.10 However, reliable bioanalytical devices that offer low cost, highly 
sensitive, multiplexed assays for clinical protein detection are still lacking. 
Another goal of this thesis is to develop a low cost, portable diagnostic platforms that can 
rapidly detect multiple cancer biomarkers with high sensitivity and specificity which will be 
valuable tools for future personalized patient care of cancer and other diseases, as well as for 
research applications requiring measurement of low abundance proteins.10 Chapter 3 of this thesis 
describes a new, low cost 3D-printed array for multiple protein detection which are chosen for 
prostate cancer. 
Chapter 4 briefly discusses a novel, low-cost, portable, and three dimensional (3-D) 
electrochemical microarray on the form of a micropipette tip for genotoxic chemistry screening. 
This electrochemiluminescent (ECL) based sensor is powered by photo-rechargable 
biosupercapacitor fabricated from reduced graphene oxide/myoglobin nanocomposites (rGMb). A 
multilayer film was layer-by-layer assembled on the array to include DNA, microsomal enzymes, 
and ECL-emitting metallopolymer. This self-powered sensor was able to detect low levels of 
Aflatoxin B1 (AFB1) to establish a proof of concept. Onsite environmental sample analysis of 
polluted water is underway. This biosupercapacitor powered sensor provides a new platform of 3-
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D printed devices capable of the onsite assessment of the relative DNA damage of environmental 
samples in developing countries and in remote areas.   
Chapter 5 presents a bifunctional, thermally stable cesium-promoted mesoporous 
manganese oxide (Cs-MnOx) for catalytic oxygen reduction reaction (ORR) and oxygen evolution 
reaction (OER).11 Extensive characterization and density functional theory (DFT) computations 
suggested that the stabilization of the surface and bulk enriched Mn3+ species, increase of relative 
basicity and maintaining active crystalline phase due to Cs incorporation, are the main decisive 
factors for the profound ORR and OER activities. Findings from this chapter provide general 
guidance for designing of cost effective and active metal oxide based electrocatalysts for alkaline 
fuel cells. 
Chapter 6 describes a novel energy harvester called ferrofluid based triboelectric 
nanogenerator (ferro-TENG) featuring diverse multi-functionality. The unique properties of the 
ferrofluid constituent of the device allowed the fabrication of TENG devices that are flexible, 
stretchable, and have the ability to sense and harvest magnetic, mechanical and acoustic energies. 
The waterproof properties of the ferrofluid-TENG made it excellent candidate for biomedical and 
under water wearables, as well as soft robotics applications which are capable of harvesting and 
sensing the water wave energy. Wearable pressure Ferro-TENG sensor enabled monitoring biceps 
and triceps resistance bands, a promising approach for flexural and stretching pressure sensing. 
Additionally, it was used for sensing and harvesting acoustic energies at different sound 
frequencies which make it a good candidate for hearing aids. Scavenging and quantification of 
magnetic field energies was a novel approach that was used to detect the magnetic field intensity 
and rotation velocity of magnetic rotatory motors. This new device provided a hybrid energy 
harvesting/sensing platform that would be used as work horse for next generation sensors 
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overcoming energy source requirements barriers. The ability of the sensor to produce measurable 
electrical signal without the need to external power source would be of interest especially in 
biomedical health monitoring, robotics and artificial skin applications. 
1-2. Current Power Sources of Pacemakers and Portable Bioanalytical Devices. 
 
All current commercially available cardiac pacemakers and portable biosensors are 
powered by batteries. For cardiac pacemakers, high energy density Li ion batteries are the most 
commonly used. However, powering such implanted devices by batteries creates problems,12 
because these devices must be replaced when the battery is drained. This necessitates that the 
patient undergo painful surgery at significant expense. Furthermore, the bulky size and the high 
toxicity of the components prevents the final device miniaturization and pose a safety threat in 
case of leakage. In addition, electronically simple, miniature power sources are also important for 
clinical biosensor development. Most current immunosensing technologies are based on ELISA 
which rely on heavy instrumentation that need electrical cord for power supply. Research efforts 
have explored different power sources such as enzymatic fuel cells and portable solar panels.13  
1-3. Bioelectrochemical Capacitors (bECs) or Biosupercapacitors. 
 Biosupercapacitors are electrochemical capacitors that utilize biological materials to store 
electrical energy at much higher power density than batteries.14 This new class of supercapacitors 
is composed of two electrodes of nano-engineered biomaterials sandwiching a porous separator. 
They store the electrical energy at the electrode-electrolyte interface mostly through the reversible 
adsorption of ions which enables fast charging and discharging processes. On the other hand, 
implantable energy harvesters enabled the direct harvest of the body motion and heat into electrical 
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current. In order to rely on energy harvester as a power source, the electrical energy generated 
should be immediately stored to be used when needed by the pacemaker.  
 
These new biosupercapacitors can act efficiently as intermediary energy storage devices 
that quickly store the electrical current generated by implantable or wearable energy harvesters 
and discharge it to the output implantable pacemaker or wearable biosensors (Figure 1-1). More 
importantly, this supercapacitor works like an inverter to rectify the alternating current resulting 
from the harvester into direct current needed for the operation of almost all implantable devices. 
These biosupercapacitors may be suitable to power a broad range of implantable devices other 
than cardiac pacemakers such as gastric pacemakers, deep brain, bladder, and bone stimulators, 
automated drug delivery systems, artificial vision, and biosensors.15 
 
Figure 1-1. Scheme illustrating our vision for the brGO/Mb bECs (center panel) as micro-
power sources for biomedical implants. Energy harvesters in the left panel were adapted from 
Reference 3, and 4. 
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Graphene-protein biosupercapacitors: 
 
Figure 1-2. Relationship between Energy and power densities of a brGO/Mb bEC in a cell 
culture medium as compared to commercial EDLC, 300 F/3V aluminum electrolytic capacitor, 
12 Ah/3.3V Li thin film battery, and 500 Ah/5V Li thin film battery. 
Rationally designed green and sustainable ultrathin biosupercapacitors were fabricated 
from graphene and protein layer-by-layer assembled electrodes, and porous nontoxic separator. 
Made out of ~ 0.1 micron thick electrodes, these biosupercapacitors promise to reduce the size of 
current implantable devices by more than 50%. They also utilize human and mammalian biofluids 
as electrolytes, replacing the standard toxic electrolytes commonly used in regular capacitors and 
lithium ion batteries. The energy density of the graphene-protein biosupercapacitors reaches up to 
1.8 mWh/cm3, which is up to 11 times higher than commercially available thin-film 
electrochemical capacitors (Figure 1-2). Their energy density is also comparable to that of Li thin 
film battery but with at least 100 times higher power density which make them unique in fast 
charging and discharging applications. These biosupercapacitors are flexible and fully bendable 
up to 180o without compromising their excellent electrochemical performance. These results 
suggest the suitability of the proposed supercapacitors for implantable and wearable applications 
(Figure 1-3). 
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.  
Figure 1-3. Cyclic voltammograms for graphene-protein biosupercapacitors showing no 
damage of performance upon bending of the device to angles up to 180o. 
 
1-4. Self-Powered Sensors/Energy Harvester Systems. 
 
Tremendous efforts were directed to find power sources which are clean and renewable.16 
Harvesting energy directly from waste mechanical energy found in surrounding environment such 
as raindrops, human footfalls, air flow, and ocean waves provides a promising and cost-effective 
solution for clean electric power.17 One the most successful methods for the conversion of the 
mechanical into electrical energy is based on the coupling of the triboelectric and electrostatic 
effects in a triboelectric nanogenerator (TENG), where contact between two materials with 
different triboelectric polarities leads to charge transfer at their interface. The separation of these 
materials induces a dipole moment, which drives the electrons transfer by applying the external 
loads on the nano-structured interface of two triboelectric active materials. The TENG as a charge-
pump device could also provide current flow back and forth between the electrodes to get an 
alternating current (AC). Therefore the charge transfer at interfaces in TENGs is the dominant 
phenomenon, which is required to be controlled via chemical and physical structure design to 
achieve high electric power density energy harvester/sensor systems. Not only does this interface 
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design and charge transfer lead to efficient lab-scale devices but also guarantee its potential and 
efficiency for larger scale production. 
The appearance of current during contact and separation is a definite indication of charge 
transfer occurring at the interface. However, it is difficult to adequately define the charge carriers 
nature (i.e., electrons, holes, ions, etc.) involved in such a transfer at the interface, where the charge 
formation by bond-breaking and material transfer in polymer dielectrics is also plausible. It should 
be noted that the observation of bipolar charging (bi-directional transfer) at contact point implies 
the complex nature of charge transfer mechanism; however, unidirectional electron transfer via the 
proposed mechanism of charge formation through bond breaking might help in the understanding 
underlying mechanism.18 Figure 1-4 shows a typical alignment of charges at the interface in 
contact/separation electrification using this recent knowledge.  
 
Figure 1-4. Illustrates the used methods to enhance Triboelectric Nanogenerator. The mentioned 
techniques mentioned in Scheme 1 will explain in the next sections in respective to real examples. 
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Before contact, both surfaces from different materials are uncharged. During the first contact, 
bipolar charges are created (conserving the total charge as, X+ = Y− + e−, where X and Y are 
mechano-ions, e− is free electrons) at the dielectric/dielectric (here polymer/metal) interface due 
to the bond-breaking processes on the polymer’s surface (as one of the dielectrics).18a At this 
moment, the generated free electrons (e−) flow from the surface appears as a simultaneous electron 
flow from the electrode 1 (Figure 1-4). Therefore, negative charges remain at the polymer’s 
(dielectric) surface, where a net negative surface charge is formed, while positive charges remain 
on the surface. This TENG devices produces current in response to external stimuli such as 
mechanical, acoustic, magnetic energies which is the basis of corresponding sensors to these forces 
as explained in details in chapter 6.  
1-4. 3-D Printing of Bioanalytical Devices. 
Additive manufacturing, or 3D printing, enables facile low cost fabrication of custom objects by 
non-experts, and is beginning to play a very significant role in manufacturing.19 Desktop 3D-printers 
can be used to rapidly design, optimize, and fabricate low cost, high performance microfluidic 
devices.20 3D-printing enables rapid prototyping of singleunit devices while avoiding expensive 
masters or masks necessary for the alternative methods of microfluidic device fabrication such as 
photo lithography and soft lithography.21 Device assembly tasks required when using precision 
cutting, molding, and machining for fabrication are minimized by 3Dprinting to produce nearly 
complete microfluidic devices. Plans for 3D-printed objects are developed using computeraided 
design (CAD) software, and the CAD file is processed to generate print instructions that are 
uploaded to the printer.20b, 22 Optimization is achieved at a fraction of cost and time of lithography, 
and the final optimized prototype becomes the usable device. While lithography can presently 
achieve better resolution than 3D-printing, ongoing advances in 3D print resolution and speed are 
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underway.23 However, stereolithographic (SLA) 3D-printers can achieve channel widths of 150 
μm and structural features of 95 μm24 and are well suited for many bioanalytical microfluidic 
devices.  
Recent analytical applications include smartphone-controlled biosensors,25 electrochemical 
sensors,20b, 26 optics for SPR,27 and other biomedical sensors.28 Our research team has 3D-printed 
microfluidic devices that include an electrochemical hydrogen peroxide sensor, 
electrochemiluminescent DNA sensor,29 a genotoxicity chemistry reactor with DNA damage end 
point,43 and prototype immunoarrays for proteins.13a, 20a Earlier, we used polymer molding to 
develop ultrasensitive microfluidic immunoarrays that detect multiple proteins by combining 
massively labeled antibody-coated magnetic beads with nanostructured electrochemical sensors.30 
Stereolithographic (SLA) printers utilize laser-assisted polymerization to print clear plastic objects. 
Thus arrays suitable for light detection can be printed, and can be improved by simple post-processing 
to high transmittance suitable for electrochemiluminescent (ECL) detection sensors.29 
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CHAPTER 2 
 
 
Ultrathin Graphene-Protein Supercapacitors for Miniaturized Bioelectronics 
 
 
 
 
2-1. ABSTRACT  
 
Nearly all implantable bioelectronics are powered by bulky batteries which limit device 
miniaturization and lifespan. Moreover, batteries contain toxic materials and electrolytes that can 
be dangerous if leakage occurs. Herein, we describe an approach to fabricate implantable protein-
based bioelectrochemical capacitors (bECs) employing new nanocomposite heterostructures in 
which two-dimensional reduced graphene oxide sheets are interlayered with chemically modified 
mammalian proteins, while utilizing biological fluids as electrolytes. This protein modified 
reduced graphene oxide nanocomposite material showed no toxicity to mouse embryo fibroblasts 
(MEF) and COS-7 cell cultures at a high concentration of 1600 g/mL which is 160 times higher 
than those used in our bECs, unlike the unmodified graphene oxide which caused toxic cell damage 
even at low doses of 10 g/mL. The bEC devices are one micrometer thick, fully flexible, and 
have high energy density comparable to that of lithium thin film batteries. COS-7 cell culture was 
not affected by long-term exposure to encapsulated bECs over 4 days of continuous 
charge/discharge cycles. These bECs are unique, protein-based devices, use serum as electrolyte 
and have the potential to power a new generation of long-life, miniaturized implantable devices. 
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2-2. INTRODUCTION 
 
Implantable medical devices have revolutionized treatment of some chronic diseases. E.g., 
modern cardiac pacemakers can monitor and control the patient’s heart function, and report critical 
events to hospital control centers. However, powering such implanted devices by batteries creates 
problems,1 because these devices must be replaced when the battery is drained. This necessitates 
that the patient undergo painful surgery at significant expense. Therefore, a few researchers are 
exploring battery-free implantable devices by harvesting energy directly from the human body,2 
e.g. from motion, body heat, hydraulic energy of the circulatory system or even from glucose in 
body fluids.3 Energy harvesters can convert this ambient energy into electricity that is sufficient to 
power many implantable medical devices.2a, 4 Unlike batteries, human-powered energy harvesters 
could power existing implants indefinitely. Recently, researchers have successfully developed an 
implantable nanogenerator in a living rat that works by extracting energy from its periodic 
breathing. This energy was used to power a prototype pacemaker.5 In another example, a mass 
imbalance oscillation generator taken from a commercially available automatic wrist watch was 
used to harvest the kinetic energy from the beating heart of a living sheep and the generated power 
(16.7 µW) was sufficient to provide 1 µW of power6  to run a pacemaker.  
Bio-friendly, protein-based batteries or supercapacitors that use human body fluids 
(serum/urine) as electrolytes and are harmless to biological systems during their functional 
performance are highly promising but currently do not exist. As a first step toward such devices, 
we demonstrate here a revolutionary, protein-based supercapacitor, which uses benign-electrolytes 
and electrode materials that are nontoxic to living cells. 
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Supercapacitors are high performance electrochemical capacitors (ECs) that store energy at 
much higher power density than batteries. Power system for implantable devices as described 
above require an intermediate energy storage system such as ECs for their operation.7 Basically, 
by storing the generated energy in an EC, the output power can periodically drive existing medical 
implants.5 However, like other implanted medical devices there are some stringent requirements 
for this EC. First, it must be safe during operation, and have predictable performance and high 
reliability.8 Second, this EC should provide service over many years with no maintenance required. 
It is also important to have high volumetric energy density to enable the miniaturization of the 
entire implanted system (Figure 2-1).  
 Compared to batteries, ECs have faster charge-discharge rates, lower internal resistance, 
higher power density, better cycling stability, and the ability to use external fluids as electrolytes.9 
These devices have the potential to power a new generation of implantable devices as cardiac and 
gastric pacemakers, deep brain, bladder, and bone stimulators, automated drug delivery systems, 
Figure 2-1. Scheme illustrating our vision for the brGO/Mb bECs (center panel) as micro-power 
sources for biomedical implants. Energy harvesters in the left panel were reprinted with permission from 
Ref. 5, and 6. Copy-rights 2014 John Wiley and Sons, and 2013 Springer respectively. 
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artificial vision, and biosensors.10 However, ECs are currently limited by relatively low volumetric 
and gravimetric capacitances, and low energy densities (energy stored per unit volume or mass) 
that are less than those of batteries.11 In addition, batteries in general are considered the least 
“green” component in any electronic device.12  They often use toxic materials and operate on liquid 
electrolytes, which can be very harmful if leakage occurs. Using such batteries for implantable 
medical devices not only make them bulky, but also raises safety concerns. Thus, rationally 
designing green and sustainable bioelectrochemical capacitors (bECs) 13 with high volumetric 
energy density is highly desirable. It is also crucial that these bECs use safe electrode materials, 
and electrolytes to living cells.  
Graphene sheets feature single layers of carbon atoms with unique electrical properties that 
are promising for designing ultrathin bECs and other novel technological applications. 14 It is an 
attractive nanomaterial for implantable bECs, given its high theoretical capacitance of ~550 F/g 
and its rich surface chemistry which enables further processing into composite materials with 
desirable properties.15 Graphene have attracted great attention for the design of ultrathin ECs. By 
attaching cation-derivatized (cationized) bovine serum albumin (cBSA) to the surface of graphene 
oxide as a nano-spacer and further deposition of heme protein myoglobin in a layer-by-layer 
process, followed by electrochemical reduction, we have developed graphene-based bECs with an 
ultrahigh volumetric capacitance in biofluids up to 655 F/cm3 at a scan rate of 100 mV/s, and 534 
F/cm3 at a current density of 2.5 A/g. Their energy density reaches up to 1.8 mWh/cm3, which is 
3 to 11 times higher than commercially available thin-film ECs. They are thinner (1.14 m) than 
a human hair and can provide high power density. Unlike pristine graphene which poses potential 
risks to human cells,16 the new hybrid material showed no signs of cell toxicity at concentrations 
160 times higher than those used in our bECs, and the encapsulated device showed no adverse 
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effects on cells after for four days of continuous charge/discharge cycles. This paper presents a 
new platform for the design of ultrathin bECs utilizing for the first time human biofluids as 
electrolytes for the development of the next generation implantable medical devices (Figure 2-1). 
2-3. MATERIALS & METHODS 
 
2-3.1. Construction of ultra-thin gold current collectors 
 
A gold compact disc (CD) was treated with 70% nitric acid in a Petri dish for 1-2 minutes 
to remove the outer polymeric layer, thus exposing a thin gold layer that has a median thickness 
of 42 ± 8 nm as measured by focused ion beam scanning electron microscope (FIB-SEM) (Fig. 
S4). The gold layer was washed with 70% ethanol and then water to remove any nitric acid 
contamination; this produces a clean thin gold current collector in a rigid plastic support. For a 
flexible current collector, the gold layer was removed from the hard plastic support under a stream 
of running water focused at the edge of the CD, then dried and transferred to the sticky side of 
very thin transparent tape, washed with DI water and then dried before use. The gold layer was 
then cut into pieces (1.0 cm2 each measured using a Varnier Calliper, and then incubated into 5 
mM mercaptopropionic acid in 70% ethanol to produce an anionic monolayer of HOOC-alkylthiol 
with the carboxylic groups directed towards the surface, ready for the binding of the next cationic 
layer. 
 
2-3.2. Assembly of graphene-protein electrode nanomaterials 
 
First, biophilized graphene oxide (bGO) was synthesized by the method described in Ref 
17. Briefly, bovine serum albumin (BSA) and 2-Ethandiamine were mixed together followed by a 
slow addition of the crosslinking agent to avoid the excessive crosslinking between BSA 
molecules. In Fig. 2a, we only represented one BSA molecule reacting with one 2-Ethanediamine 
to make the scheme simpler for presentation purpose, but there is a chance for more than one 2-
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Ethanediamine to react with one BSA which explain the efficient binding of cBSA to the 
negatively charged graphene oxide sheets. Moreover, there is also a chance of BSA molecules to 
crosslink each other while adding the crosslinking agent. Similar chemistry have been quantified 
in our recent work to be about 10 %18. Chemically modified bovine serum albumin (cBSA) was 
allowed to bind to GO through controlled addition of cBSA to GO with continuous stirring for 20 
hours to prepare bGO. A layer-by-layer assembly technique was used to alternate oppositely 
charged layers on the gold current collector to construct the electrode material. 
Poly(diallyldimethyl ammonium) chloride (PDDA) (4 mg/mL in 0.5 M NaCl) was adsorbed for 
20 min to the gold surface to assemble a cationic polyion polymeric layer. Adsorption of each 
layer was followed by washing with DI water, and drying with nitrogen. A negatively charged 
bGO (0.7 mg/ml in 10 mM phosphate buffer, pH 7.2) was then adsorbed for 30 min, followed by 
a positively charged myoglobin (3 mg/mL in 10 mM acetate buffer, pH 5.5) adsorbed for 30 min, 
and in this way, three layers of bGO were sandwiched between two layers of myoglobin, and 
named as a bGO/Mb film. Electrochemical reduction of the bGO/Mb film was then performed 
using amperometry at a constant potential of -1.2 V for 70 seconds in 10 mM acetate buffer, pH 
5.5 in 0.5 M KBr, and the resulting film named brGO/Mb. A pyrolytic graphite electrode in a 
three-electrode system was used for the selection of the best protein (Mb), the number of bilayers 
(three), and characterizing the electrochemical reduction step. 
 
2-3.3. Biosupercapacitor fabrication 
 
A thin polyvinyl acetate (PVA) separator with an average thickness of 992 nm was 
sandwiched between two brGO/Mb electrodes in a bottom up designed supercapacitor and 
wrapped with Kapton tape. PVA was first diluted in the test electrolyte solution to a concentration 
of 1-5 %. Adjustments may be needed until achieving full intact thin layer. The diluted suspension 
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of PVA was then applied to one side of the supercapacitor, left to be just partially wet, and then 
the device was assembled. The full stack thickness of the device is 1.14 m including electrodes, 
current collectors and separators. The device was then dipped into the testing electrolyte for 10 
minutes before electrochemical performance was evaluated to ensure the wetting of the separator 
and the electrodes with the test electrolyte. The device was connected to the electrochemical 
workstation through extension from the gold collector via alligator clips, while copper tape was 
used to connect the device to the electrochemical workstation when using cell culture media as 
electrolyte to avoid the possible contamination of the workstation alligator clips by the media. It 
is worth mentioning here that polyvinyl alcohol and polyvinyl acetate are both abbreviated as 
(PVA). However polyvinyl alcohol is a very common material for separators in supercapacitor 
fabrication, it was avoided in this study because of it’s toxicity as well as solubility in aqueous 
electrolytes which may result in dissolving the separator during testing unlike polyvinyl acetate. 
The mass and thickness of the thin film was characterized by the quartz crystal 
microbalance. Gold resonators (0.16 cm2) were used in these experiments. Mass/area was 
calculated from the frequency shift (F) according to the following equation: 
 10  x 1.832 x )(g/cmM/A 82  (Hz)ΔF                                                                                    (10) 
Nominal film thickness (d) was calculated from F due to adsorption of the film on one side of 
the gold resonator as shown by the following equation: 
d(nm) = -2 (0.016) F (Hz) (11) 
Nominal film thickness of 3 layers of brGO alternated with two layers of Mb was 32 nm as 
measured by QCM. The film thickness estimated using the above expression was confirmed 
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previously by high-resolution electron microscopy2. The film thickness was averaged with 
findings from focused ion beam SEM (Fig. S4). 
2-3.4. Supercapacitor detailed calculations 
 
The specific capacitance of the device was calculated from the galvanostatic 
charge/discharge curves using the following relation: 
ΔE/Δt
Cdevice


appi                  (1) 
Where iapp is the applied current in Amperes, while -E/t is the slope of the discharge curve. 
The gravimetric capacitance of the device (Cs(device)) and the stack volumetric capacitance 
(Cv(stack)) were calculated using the following equations: 
M
C
C
device
s(device)                     (2) 
 
V
C
C
device
v(stack)                      (3) 
where M is the total mass of the active films on both electrodes, while V is the total volume of 
the device including flexible supports, current collectors, active films, and separator (but not the 
packaging). Capacitance/area was calculated by replacing the volume of the device in Equation 3 
with the device area. The gravimetric capacitance of the electrode (Cs(electrode)), and the 
volumetric capacitance of electrode (Cv(electrode)) are given by the following formulas: 
 
4  x CC  (device) s)(electrode s              (4) 
electrode
device
)(electrode v
V
C  2
C
x
             (5) 
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The internal resistance (R) of the supercapacitor was calculated through dividing the voltage drop 
(Vdrop) (measured at the beginning of the discharge curve) by the applied current as follows: 
app
drop
ix
V
  2
R                         (6) 
Power density (P) in W/kg and energy density (E) in Wh/kg were measured for the whole device 
using the following equations: 
t
E
 P                                  (7) 
2
 (device) Vx C
 M 2
1
E                          (8) 
Where t is the discharge time of the stacked device, V is the operating potential window for the 
discharge curve subtracted from the Vdrop, and M is the total mass of the active material of the two 
electrodes in grams, while Cs(device) is the gravimetric capacitance of the device obtained from 
Equation 2. 
The device capacitance was calculated from cyclic voltammograms using the following integral 
relation: 
Ex
i
nV
V
device



1
)V-(V
C
12
                 (9) 
where i, V1, V2,  and E are the measured current, the starting voltage, the ending voltage, the 
scan rate, and the operating potential window. 
2-4. RESULTS & DISCUSSION 
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2-4.1. Layer-by-layer assembly of graphene-protein nanocomposite 
 
To fully realize the potential of graphene for implantable capacitive energy storage, we 
designed a bottom up approach for the assembly of ultrathin graphene-protein based electrodes 
(Figure 2-2). We fabricated these bECs using bGO, a novel biophilized graphene oxide (bGO) 
nanocomposite that we developed featuring graphene oxide sheets (GO) modified with cationized 
bovine serum albumin (cBSA). The latter material is BSA with chemically attached protonated 
amine groups to enhance positive charge and proton transfer capacity.17 We then used layer-by-
layer (LbL) deposition19 to fabricate electrodes of alternate layers of bGO and myoglobin (Mb) 
onto a 1.0 cm2 ultrathin gold sheet to form several bGO/Mb bilayers (note: one bilayer refers to 
one bGO layer). Then bGO/Mb was electrochemically reduced to brGO/Mb (brGO = biophilized 
reduced graphene oxide) (Figure 2-2g). A film of three layers of brGO sandwiching two layers of 
Mb gave the largest capacitance per unit volume, up to 534 F/cm3 in human urine at 2.5 A/g 
(contribution of current collector and separator is subtracted, see supplementary information for 
details). bEC devices made from these electrodes were able to utilize cell culture media, and 
mammalian biofluids as electrolytes for high capacitance output with no measurable signs of 
cytotoxicity in cell culture media.  
In this design cBSA and Mb should render graphene more compatible with living cells, 
and provide a good source of heteroatoms to improve the specific capacitance of graphene by 
introducing pseudocapacitive behaviour.20 These proteins have a good adsorption character and 
their charge can be easily controlled by changing the pH which make them an excellent candidate 
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for electrode fabrication. Moreover, proteins act as polyionic nano-spacers to prevent the 
restacking of graphene that often limit the access of the ions to the sheets and undermines its 
Figure 2-2. Illustration of the electrode fabrication. (a) Preparation of cationized bovine serum albumin 
(cBSA) by coupling the COOH groups of BSA with tetraethylenepentamine. (b) Adsorbing cBSA onto GO 
sheets. (c) Gold current collector with monolayer of mercaptopropionic acid, and a layer of polycation 
Polydiallyldimethylammonium chloride (PDDA) adsorbed on top. (d) Adsorption of bGO, (e) Adsorption 
of Mb, (f) Film from LbL assembly of three bGO layers alternated with two Mb layers (abbreviated as 
bGO/Mb). (g) Electrochemically reduced film (abbreviated as brGO/Mb). 
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electrochemical performance. A gold current collector was employed in the cell design, since gold 
is among the safest materials for medical applications.21 Other designs have been reported  
using reduced graphene oxide assembled with polymers that achieved good capacitive 
performance, but using toxic polymers as part of their electrode materials as well as using toxic 
electrolytes saturated separators limit their use for implantable biomedical applications.15b 
 
2-4.2. Characterization of graphene-protein nanocomposite  
 
In order to understand the capacitive behavior of these graphene-protein bECs, different 
protein films were LbL assembled with brGO (three brGO layers sandwiching two protein layers) 
and their electrochemical performance was evaluated using charge/discharge curves and cyclic 
voltammetry (CV) (Table 2-1; Figures 2-3 and 2-4).  
Table 2-1: Structural analysis of proteins in relationship to the protein capacitive performance in 
LbL assembled film with brGO. 
Proteins 
Molar 
mass 
(g/mol) 
aTotal 
number 
of 
charged 
residues 
b# charged 
residues/Molar 
mass 
(Mole/gram) 
X 10-3 
c#  charged 
residue in 5 g of 
protein (g -1) 
 
X 1015 
Areal 
capacitance 
(F/cm2) 
Myoglobin 17083 53 3.1 9.3 1525 
Cytochrome C 11370 29 2.6 7.8 1175 
Haemoglobin 62276 154 2.5 7.4 1100 
Glucose 
oxidase 65638 124 1.9 5.7 
1010 
Catalase 59915 147 2.5 7.4 850 
a: The total number of charged residue represents the total number of charged amino acids 
residues (Hist, Lys, Arg, Glu, Asp) in the protein (protonable sites). b: represents the total number 
of charged amino acid residues divided by the molar mass of the corresponding protein, and c: 
represents the total number of charged amino acids residues divided by the mass of the film 
(Assuming a mass of 5 g of protein film). Data in the first two columns are extracted from the 
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Uniprot protein data bank (PDB). The IDs of Mb, Cyt C, Hb, Gox, and Cat are P68082, P81459, 
P01966, P13006, and P00432 respectively. 
Utilizing calf serum as electrolyte at a current density of 0.005 mA/cm2, Mb showed the 
highest areal capacitance reaching 1526 F/cm2, followed by cytochrome-C (Cyt-C) with a 
capacitance of 1175 F/cm2, then haemoglobin (Hb), glucose oxidase (GOx) and finally catalase 
(Cat) in order of decreasing the areal capacitance (Figure 2-3; Table 2-1).  
 
Figure 2-3. Charge discharge curves for the different proteins LbL assembled with three brGO 
layers, followed by electrochemical reduction. among other proteins. Mb: myoglobin, Cyt-C: 
cytochrome C, Hb: haemoglobin, GOx: glucose oxidase, Cat: catalase. 
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Figure. 2-4. Cyclic voltammograms of films of brGO assembled with different proteins on a 
pyrolytic graphite electrode in a three-electrode system at a scan rate of 1000 mV/s in 1.0 M 
Na2SO4 as a neutral electrolyte. Cationic proteins were prepared in buffers at pHs lower than the 
isoelectric point of each tested protein. LBL assembly of three bGO layers with two protein layers 
were carried out, and followed by electrochemical reduction. The brGO/Mb film showed the 
highest capacitance among other proteins. Mb: myoglobin, Hb: haemoglobin, Cyt-C: cytochrome 
C, GOx: glucose oxidase, Cat: catalase. 
Proteins are rechargeable molecules by protonation/deprotonation through their charged 
residues, ie. charged amino acid side chains (lysine, arginine, histidine, glutamic acid, and aspartic 
acid).22 Protonation/deprotonation can be used by organic compounds to store the capacitive 
charge, which has been demonstrated for their use in ultrafast supercapacitors.23 By calculating the 
total number of charged amino acid residues (protonable sites) in each protein and normalizing 
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them to the molar mass of the protein, a strong correlation with the areal capacitance was 
discovered (Figure 2-5i; Table 2-1). Myoglobin had the highest ratio of charged residue/molar 
mass (Z/M) and the highest areal capacitance, followed by Cyt-C, Hb, and GOx in order of 
decreasing both the Z/M ratio and the areal capacitance (Figure 2-5i; Table 2-1). Catalase showed 
moderate Z/M ratio but exhibited low areal capacitance due to its large molecular size and highly 
negative hydropathy index (Figure 2-5i; Table 2-1). This suggest a key role of number of 
protonable sites in the capacitive performance of the graphene-protein films. Based on these 
results, Mb nanocomposite with brGO was chosen and further explored for the development of 
bECs. 
Characterization of the brGO/Mb electrode using scanning electron microscopy revealed 
that brGO/Mb films adsorbed to the striated gold current collectors were continuous and relatively 
uniform. Tapping mode atomic force microscopy (AFM) images showed a uniform first layer of 
PDDA (Figure 2-5a). The adsorption of bGO results in a continuous layer of overlapping GO 
sheets with small islands of cBSA as shown in Figure 2-5b. The incorporation of the Mb layer 
increases the film roughness due to its globular nature (Figure 2-5c). Addition of another layer of 
bGO on this surface results in a sheet-like covering on the Mb layer (Figure 2-5d). Overall, AFM 
images reveal the homogeneous coating of the LbL on the gold current collector. 
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Figure 2-5. Characterization of the graphene-protein hybrid electrodes. (a-d) Tapping mode AFM 
images of the layer-by-layer assembled film on a mica disc. (a) PDDA, (b) PDDA-bGO, (c) PDDA-
bGO-Mb, and (d) PDDA-bGO-Mb-bGO. (e) Change in the mass/area, and nominal thickness of the film 
as a function of the number of layers assembled as measured by quartz crystal microbalance (QCM). (f) 
Raman spectra of films before and after electrochemical reduction. (g) Myoglobin binding to GO (red 
curve) and bGO (blue curve) in 10 mM acetate buffer at pH 5.5 as a function of increasing concentrations 
of myoglobin. (h) Circular dichroism spectra suggesting extensive denaturation of Mb upon binding to 
either GO or bGO. (i) Areal capacitance of three bilayers of brGO/protein in correlation to the number 
of sites available for protonation/deprotonation normalized by the molar mass of proteins. Cyt-C, Mb, 
Hb, GOx, and Cat stand for Cytochrome-C, myoglobin, hemoglobin, glucose oxidase, and catalase, 
respectively. The highest areal capacitance among these proteins was observed with brGO/Mb film. 
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 We used quartz crystal microbalance (QCM) to monitor and control the LbL assembly of 
the electrode material. We observe from Figure 2-5e that the bGO/Mb film grows almost linearly 
as a function of the number of layers. The electrochemical reduction of this bGO/Mb film is 
associated with a decrease in the electrode mass and thickness, suggesting the successful removal 
of residual oxygen functionalities from the surface of the graphene oxide.24 QCM estimates a 
nominal thickness of 32 ± 2 nm for the brGO/Mb active film (Figure 2-5e; see Supplementary 
information for more details), while SEM cross-section imaging after cutting with a focused ion 
beam gave 26 ± 5 nm for the same film (Figure 2-6). Thus, the average thickness of 
brGO/Mb/brGO/Mb/brGO from the SEM and QCM was 29 ± 4 nm. Analysis of the films by 
Raman spectroscopy showed an increase in the ratio of the D band to the G band (ID/IG) for brGO 
(1.1) compared to bGO (0.94) (Figure 2-5f), suggesting that the reduction resulted in structural 
modification of graphene oxide sheets with the introduction of defects. Moreover, the 2D and S3 
bands showed notable increases after reduction suggesting the better graphitization in brGO.25  
 
Figure 2-6. Focused ion beam- scanning electron microscope (FIB-SEM) images measuring 
the brGO/Mb film thickness on a gold CD underlayer. The figure shows a side view of the 
brGO/Mb film on a gold under layer with platinum protective coating on the top, the image shows 
a uniform gold underlayer (42 ± 8 nm), with a uniform brGO/Mb film (26 ± 5 nm) on the gold.   
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The unique spacing achieved by Mb spreading on the bGO reduced the extent of л-л 
stacking between adjacent layers and separated them more efficiently (Figure 2-7).  
 
Figure 2-7. Cross section of thick film of brGO/Mb prepared by drop casting on a glass slide to 
visualize the coating of the proteins on the GO layers. 
This was confirmed by the shift of the characteristic GO X-ray powder diffraction (XRD) 
peak in the bGO/Mb film to a lower diffraction angle as compared to the as-prepared GO indicating 
the increase of the intersheet distance due to Mb spacing (Figure 2-8). 
 
Figure 2-8. XRD powder patterns of the as prepared GO in comparison to LbL assembled 
bGO/Mb film showing the shift of the XRD peak to smaller diffraction angle indicating the role 
of myoglobin in spacing the GO sheets. 
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In addition, Raman spectra of different proteins bound directly to GO were compared to 
the Raman spectrum of the GO only sample. Results show that the Mb-GO film has a sharp, 
relatively high intensity 2D peak compared to other proteins bound GO or the as-prepared GO 
sample indicating fewer layers of GO sheets and hence better spacing in case of GO/Mb films 
(Figure 2-9). This may be attributed to the small size and the higher electrostatic attraction of Mb 
to GO because of Mb’s higher Z/M ratio. 
 
Figure 2-9. Raman spectra for the as prepared graphene oxide (GO) before and after the direct 
binding to different proteins. The spectra show higher 2D band in case of GO bound to myoglobin 
in compared to all other proteins or GO alone. 
 Binding of Mb to bGO was quantified and the bound protein structure examined by circular 
dichroism (CD) spectroscopy (Figures 2-5g-h). CD spectra indicated a loss of secondary structure 
of the bound Mb. Other proteins were also tested as alternatives to Mb, most of these retained their 
secondary structures on binding to bGO,20b but capacitive performance was the best with Mb 
(Figure 2-5i).  
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Figure 2-10. Comparison of capacitive behavior of composites of previously cationized graphene 
oxide (bGO) and native graphene oxide (GO), both assembled in three bilayers with Mb and 
electrochemically reduced using the same procedure. Also 5 g/cm2 of GO was loaded to 
electrodes, electrochemically reduced, and tested for the capacitive behavior for comparison. CVs 
were recorded at 1000 mV/s in 1.0 M Na2SO4 as a neutral electrolyte in a three-electrode system, 
using pyrolytic graphite as the working electrode. The figure demonstrates the superior 
performance of the bGO containing film. 
Proteins in the film increased the capacitance per unit area, up to 5 times when compared 
to the capacitances of the corresponding films made from drop casted reduced graphene oxide, 
which lacked the proper spacing of sheets and the pseudocapacitance of the heteroatom rich 
interlayers (Figure 2-10) with charged residues and protonable sites which are required for charge 
storage by protonation/deprotonation as the brGO layers are charged-up. In addition, brGO 
interlayered with Mb (brGO/Mb) showed ~ 2 times higher capacitance versus brGO only films 
drop casted on the electrodes (Figure 2-11), indicating the important capacitive role of Mb in 
brGO/Mb films.  
38 
 
 
Figure 2-11. Electrochemical performance of brGO/Mb electrodes vs. brGO electrodes (without 
Mb) in three electrode cell, with SCE as reference electrode. (A) Cyclic voltammograms at 0.005 
V/s in 0.1 M LiClO4. (B) Charge/discharge cycle at 2 A/g in 0.1 M LiClO4. 
The electrochemical reduction of the film was achieved in 10 mM acetate buffer, pH 5.5 
containing 0.5 M KBr at constant potential -1.2 V vs. SCE for 70 s. The reduction of bGO in the 
film to brGO was indicated by the change of film color from brown to black, and is supported by 
a reduction peak for bGO found at -0.95 V vs. SCE by cyclic voltammetry (CV) that disappears 
upon subsequent scans (Figure 2-12). In addition, a dramatic increase in capacitance was found 
after bGO reduction to brGO (Figure 4a, and Figure 2-12). CV profiles showed characteristic 
FeIII/FeII peaks of Mb at -0.3 V vs. SCE in acetate buffer, the characteristic peaks appeared before 
and after reducing the film for 3 s, but continued reduction for 70 s caused a large increase in the 
charging current and loss of the Mb peaks (Figure 2-12). 
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2-4.3. Electrochemical performance of biosupercapacitors 
 
The hemin center of hemoproteins is an important active center for a number of catalytic 
reactions,26 and was also reported to contribute to capacitance of thick proteins films supported on 
nickel foam electrodes.27  However, loss of the characteristic redox peaks of the FeIII/FeII of the 
hemin center after electrochemical reduction (Figure 2-12), along with the loss of the protein 
secondary structure as revealed by CD (Figure 2-5h), confirm that Mb is denatured in the 
brGO/Mb electrodes and the hemin center is lost or deactivated, which suggests a minor role of 
the FeIII/FeII hemin redox couple in the capacitive behavior of the brGO/Mb electrodes. 
 Myoglobin has the highest Z/M ratio among the studied proteins, and yet Mb-only films 
had low specific capacitance of 16.6 F/g (Figure 2-13).  
Figure 2-12. Monitoring the electrochemical 
reduction, and its effects on capacitance. (a) 
Repetitive cyclic voltammograms for 
electrochemical reduction of bGO/Mb film on 
pyrolytic graphite. CV indicates the disappearance of 
the reduction peak at -0.95 after the first cycle, 
confirming the irreversible reduction of bGO to 
brGO. (b) Cyclic voltammogram for the bGO/Mb 
film before the reduction showing the characteristic 
myoglobin peaks. (c) Comparison of CV before (red) 
and after (blue) reduction causing a dramatic 
increase in capacitance and a significant decrease of 
Mb peaks. CVs of A, B and C were taken at 100 
mV/s, in 10 mM acetate buffer, pH 5.5, containing 
0.5 M potassium bromide. For more efficient 
reduction, amperometric reduction at a more 
negative potential (-1.2 V versus SCE) was used for 
reducing the bGO/Mb film for all characterization 
and device fabrication. 
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Figure 2-13. The electrochemical performance of Mb electrodes. (A) Cyclic volatommogram at a 
scan rate of 0.025 V/s in 0.1 M Na2SO4. (B) Charge/discharge cycle of Mb electrode at 6 A/g. 
The low capacitance of Mb in the absence of graphene is due to the poor electrical 
conductivity of Mb-only films. The electrical conductivity of the Mb alone and in the LbL 
assembled film with brGO were measured using the 4 probe technique. Mb showed low electrical 
conductivity of 3.6 10-8 S/cm at room temperature due to its insulating nature which explains the 
poor electron flow through thick Mb films and its low specific capacitance. However, the 
introduction of brGO to the Mb films increased the electrical conductivity by about 5 orders of 
magnitude reaching 0.003 S/cm at room temperature. The electrical conductivity of the brGO/Mb 
electrode was further explored at different temperatures using a two electrodes set up (Figure 2-
14). The brGO/Mb electrode showed good thermal stability and increase in conductivity as the 
brGO/Mb electrode was heated up to 150 oC, suggesting that the brGO/Mb electrodes are thermally 
stable at temperatures far beyond those needed for implantable applications. 
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Figure 2-14. The effect of temperature on the electrical conductivity of the brGO/Mb electrode.  
The electrochemical performance of the brGO/Mb electrodes was further studied to assess 
capacitive efficiency as implantable bECs. The capacitive behavior depends strongly on the 
number of bilayers. The areal capacitance increased almost linearly up to 3 bilayers, after which a 
plateau is observed (Figure 2-15). This is likely due to the low conductivity of the Mb layers that 
limits electron transport between the top layer and the current collector for thicker films.  
 
Figure 2-15. Cyclic voltammograms showing the effects of increasing the number of bilayers of 
brGO/Mb on the current density. LbL assembly of the films was carried out on pyrolytic graphite 
electrodes and tested in a three-electrode cell in 1.0 M Na2SO4 electrolyte at 1000 mV/s. Three 
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bilayers of brGO/Mb showed the highest current density with no further enhancement from adding 
more layers.  
The capacitance functionality of each of the five layers of the brGO/Mb film and the 
supports were evaluated in calf serum using charge/discharge curves at 0.005 mA/cm2 (Figure 2-
16 and Figure 2-17; Table 2-2). The areal capacitance of the positively charged gold current 
collector (with PDDA adsorbed on the surface) is 90 µF/cm2 which represents ~ 6 % of the areal 
capacitance of the final brGO/Mb electrode.  
 
Figure 2-16. Charge discharge curves for the different layers of the brGO/Mb film in calf serum 
at current density of 0.05 mA/cm2. All layers were assembled on the Au-PDDA current collector.   
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Figure 2-17. Charge/discharge curves for brGO/Mb electrode in comparison to support materials 
in calf serum at 0.05 mA/cm2. 
The capacitance of the current collector was subtracted from the capacitance of all other 
samples. The adsorption of the first bGO layer followed by electrochemical reduction to brGO 
resulted in a 2.0 µg/cm2 brGO layer as measured by QCM with an areal capacitance of 462 µF/cm2 
and a gravimetric capacitance of 232 F/g. The first brGO layer represents 40 % of the mass of the 
final brGO/Mb film and 30.3 % of its areal capacitance. The adsorption of the positively charged 
Mb as a second layer resulted in a significant increase in the areal capacitance reaching 847 µF/cm2 
and increasing the gravimetric capacitance of the assembled film to 260 F/g indicating the key role 
of myoglobin in enhancing the capacitive performance of the device. The areal capacitance 
increased by adding more brGO and Mb layers achieving the maximum areal and gravimetric 
capacitance after five layers (brGO-Mb-brGO-Mb-brGO) with 1526 µF/cm2 and 306 F/g 
respectively (Figure 2-16;  Table 2-2). A similar film was prepared by replacing the bGO with 
GO for the LbL assembly with Mb followed by electrochemical reduction to form rGO-Mb-rGO-
Mb-rGO electrode abbreviated as (rGO/Mb) resulting in a gravimetric capacitance of 239 F/g 
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which is 22 % less than the brGO/Mb electrode. The significant capacitance contribution of cBSA 
is due to its high charged amino acid content with 198 protonable sites28 per molecule scoring the 
second highest Z/M ratio (0.003) of the studied proteins after Mb. These results show the 
capacitive contribution of the proteins (cBSA and Mb) in enhancing overall capacitive behavior 
(Figure 2-17). Based on these results, electrodes of 3 brGO layers alternated with 2 Mb layers 
achieved the maximum capacitance and were used for the subsequent device fabrication. 
 
Table 2-2. The Areal and gravimetric capacitance as well as the mass calculated from the quartz 
crystal microbalance for the different layers of the brGO/Mb film and the support materials. 
Layers 
Areal capacitance 
in (F/cm2) 
Mass from QCM 
(g/cm2) 
Gravimetric 
capacitance (F/g) 
Au current collector 90 N/A N/A 
brGO 462 2.0 232 
brGO-Mb 847 3.3 260 
brGO-Mb-brGO 1057 3.9 267 
brGO-Mb-brGO-Mb 1386 4.6 300 
brGO-Mb-brGO-Mb-brGO 1526 5.0 306 
rGO-Mb-rGO-Mb-rGO 935 3.9 239 
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A photograph of a prototype implantable bEC is shown in Figure 2-18c. It was assembled 
from two brGO/Mb/brGO/Mb/brGO electrodes bound to a flexible thin gold foil with a thickness 
Figure 2-18. Electrochemical behavior of a brGO/Mb bEC. (a) Cyclic voltammetry (CV) at 
300 mV/s of non-reduced film (bGO/Mb), and electrochemically reduced film (brGO/Mb) for 3 
and 70 seconds. (b) Optimization of the film capacitance with the number of bilayers showing the 
highest capacitance for 3 bilayers. (c) Photograph of the packageless brGO/Mb EC. (d) Cyclic 
voltammetry at 1000 mV/s of brGO/Mb film in different electrolytes. (e) Change of volumetric 
and gravimetric capacitance with moderate to high current density for a brGO/Mb electrode in 
biofluids. (f) Cyclic stability of the brGO/Mb bEC in calf serum, inset shows LED powered by 
three brGO/Mb bECs connected in series with calf serum saturated separators. (g) Volumetric 
stack capacitance of a brGO/Mb bEC at different current densities as compared to commercial 
electrical double layer capacitors (EDLC). (h) Energy and power densities of a brGO/Mb bEC in 
a cell culture medium as compared to commercial EDLC, 300 F/3V aluminum electrolytic 
capacitor, 12 Ah/3.3V Li thin film battery, and 500 Ah/5V Li thin film battery. 
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of 42 ± 8 nm obtained after etching away the plastic protective layer of a gold CD.29 To get a neat 
and ultrathin EC, a layer of polyvinyl acetate gel saturated with electrolyte was loaded onto the 
electrodes to serve as both the separator and electrolyte with an average separator thickness of 992 
nm (Figure 2-19). This simplifies the processing of the electrodes into paper-like flexible bECs. 
The total thickness of the device is 1.14 µm, providing a thin, lightweight power source for 
implantable devices. 
 
Figure 2-19. FIB-SEM images measuring the PVA separator thickness on gold CD 
underlayer. Prior to cutting with a focused ion beam, a selected zone was coated with a platinum 
layer to protect the sample from being damaged by the ion beam. The figure shows a side view of 
one the porous PVA separators with an average thickness of 992 nm. The figure shows the plastic 
support of the CD, the thin gold layer used as the current collector, the PVA porous membrane, 
the platinum protective coating, and the damaged unprotected PVA membrane. 
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The packageless brGO/Mb bEC effectively utilized different biofluids in the surrounding medium 
as electrolytes including calf serum, cell culture media and human urine. For comparison, we also 
tested the brGO/Mb bEC in 0.1 M sulfuric acid, a typical standard electrolyte (Figure 2-20).  
 
Figure 2-20. Electrochemical behavior of a brGO/Mb supercapacitor in 1.0 M H2SO4. (a) 
Galvanostatic charge/discharge curves at different current densities (2.5 - 25 A/g). (b) Cyclic 
voltammograms at different scan rates (25 - 2000 mV/s) showing nearly rectangular CV curves up 
to 500 mV/s.  
It is important for ECs with high energy density to be characterized at high scan rates,30 
specially when used as a power source for implantable bioelectronics. This enables the fast 
charging of the current received from the nano-generator and the fast discharging of the electrical 
signal to the implantable devices by the bEC. Therefore, we presented the bEC device capacitive 
performance at moderate to high current density and high scan rate ranges (2-21).  
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Figure 2-21. (a) Change of volumetric and gravimetric capacitance with scan rate for a brGO/Mb 
electrode in biofluids at moderate to high scan rate. (b) Change of volumetric and gravimetric 
capacitance with scan rate for a brGO/Mb electrode in 1.0 M sulfuric acid as a standard electrolyte. 
(c) Cyclic stability of the brGO/Mb bEC in calf serum compared with acid, the inset shows the 
charge-discharge curves in acid medium at a current density of 25 A/g. 
 
Results show nearly rectangular CV shapes even at high scan rates of 1000 mV/s, 
indicating nearly ideal capacitive behavior (Figure 2-18; Figures 2-22). The maximum volumetric 
capacitance in biofluids (after subtracting the contribution of current collectors) was 655 F/cm3 at 
scan rate of 100 mV/s and 534 F/cm3 obtained at a current density of 2.5 A/g in human urine, while 
the volumetric capacitance in calf serum was 563 F/cm3 at 100 mV/s and 372 F/cm3 at 2.5 A/g 
(Figure 2-18e; Figure 2-21). It is possible that the capacitance depends on the availability and 
type of ions present in these different electrolytes, illustrated by a 14% drop in capacitance when 
changing from human urine to calf serum (Figure 2-21). The short term cycling stability of the 
packageless bEC turns out to be excellent with only a 2% drop in capacitance after 5000 cycles in 
calf serum (Figure 2-18f). This good cycling performance in biofluids suggests the short-term 
stability of the packageless bECs operating in biological environment, while the long term stability 
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and toxicity of the device will be further tested while the device is dipped in living cell culture 
(Figure 5). 
 
Figure 2-22. Electrochemical behavior of a brGO/Mb supercapacitor in calf serum. (a) 
Galvanostatic charge/discharge curves at different current densities (2.5 - 25 A/g). (b) Cyclic 
voltammograms at different scan rates (25 - 2000 mV/s).  
The excellent performance of brGO/Mb bECs was also confirmed from charge/discharge 
cycles (Figure 2-18g, and Figure 2-23). Depending on the type of electrolyte, the brGO/Mb bEC 
can provide a high stack capacitance of approximately 13-16 F/cm3. This was calculated based on 
the volume of the device stack, which includes the gold current collector, active materials, 
electrolyte and separator. When compared with commercial electric double layer capacitors 
(EDLCs), the brGO/Mb can provide 25 to 400 times higher stack capacitance.  
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Figure 2-23. Electrochemical behavior of a brGO/Mb supercapacitor in human urine. (a) 
Galvanostatic charge/discharge curves at different current densities (2.5 - 25 A/g). (b) Cyclic 
voltammograms at different scan rates (25 - 2000 mV/s). 
 
Not only does the brGO/Mb device provide higher capacitance, but also exhibits excellent 
rate capability at high current densities up to 20 A/cm3 (Figure 2-18g). This remarkable 
performance can be attributed to the microstructure of the electrode featuring brGO/Mb layered 
films featuring different pore sizes due to the protein interlayers which may facilitate the ion 
movement during charge/discharge process (Figure 2-24).31  
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Figure 2-24. BET N2 sorption of brGO/Mb. (B) Barrett–Joyner–Halenda (BJH) desorption pore 
size distribution.  
In order to demonstrate the overall performance of the brGO/Mb bEC, we calculated its 
energy density and power density and the results are displayed in a Ragone plot (Figure 2-25). 
The brGO/Mb bEC displays a high energy density of 1.1 Wh/kg at a high power density of 116 
W/kg, calculated based on the total mass the device stack as illustrated in Figure 2-25. We have 
also produced the same plot using the volume of the device stack (Figure 42-18). For comparison, 
we also tested the energy density and power density of a 300 µF/3 V aluminum electrolytic 
capacitor, 12 µAh/3.3 V Li thin film battery, 500 µAh/5 V Li thin film battery and three 
commercially available EDLCs designed for small scale applications. The brGO/Mb bEC can 
provide a high energy density of 1.8 mWh/cm3, which is comparable to Li thin film batteries and 
3 to 11 times higher than thin film commercial EDLCs. The brGO/Mb device can also deliver 
about 100 times higher power density than Li thin film batteries which is sufficient to drive all 
implantable medical devices known to us (Figure 2-18). It is worth mentioning here that the 
purpose of this work is to design ultrathin bECs for miniaturized implantable devices and therefore 
a comparison with conventional thick film electrodes seems irrelevant.  
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Figure 2-25. Ragone plot of a brGO/Mb supercapacitor in an acid showing high energy density 
up to 1.1 Wh/kg at high power density.  
The brGO/Mb system described here is the first graphene-protein bEC, and shows 
superlative characteristics as a power source for implantable devices. For example, proteins have 
been used as a source for carbon electrodes by graphitization at 800 oC.32  These devices do not 
feature intact proteins, and have low capacitance. Redox hemin based proteins were used to 
enhance pseudo-capacitance on a nickel foam, but again low specific capacitances were obtained 
(e.g., hemoglobin 12 F/g) due to the low of conductivity of the protein only films.27 In addition, 
supercapacitors fabricated from a biofilm of the conductive bacteria Geobacter sulfurreducens 
which is rich in cytochrome C protein was reported.33 Using the live conductive bacterial biofilms 
as electrode material resulted in low specific capacitance, potential loss of conductivity after the 
bacteria die, and risks of infection if used in implantable biomedical devices. On the other hand, 
previous reports of DNA based ECs have been tested for their adverse effects on living cells, and 
showed moderate to no toxicity signs on cells, but they had at best 6 times lower gravimetric 
capacitance  than brGO/Mb bECs.34 
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2-4.4. Toxicity Study of Biosupercapacitors in Mammalian Cell Culture  
 
Toward developing safe implantable bECs, toxicity and adverse effects of materials used 
to fabricate the bEC electrodes was studied using living mammalian cells. The toxicity of different 
concentrations of the as-prepared graphene oxide (GO) and graphene oxide modified proteins 
(bGO/Mb) on COS-7 and mouse embryo fibroblast (MEF) cell lines was evaluated by optical 
microscopy and spectrophotometrically by employing WST-8 dye (Water-soluble Tetrazolium 
Figure 2-26. Toxicity of bGO/Mb vs. the as-prepared GO. (a-c) Optical microscopy images of 
COS-7 cells, scale bare is 10 m. (a) Healthy control COS-7 cells without addition of any graphene 
based materials. (b) COS-7 cells co-incubated for 48 hrs with 1600 g/mL protein modified 
graphene oxide (bGO/Mb) showing no adverse effects on cells compared to control. (c) COS-7 
cells co-incubated for only 8 hrs with 25 g/mL of the as-prepared GO showing sever cell damage. 
(d) Dose-dependent toxicity in COS-7 and MEF cells co-incubated with GO for 8 hrs, measured 
in terms of the intracellular dehydrogenases (IDH) activity. (e) No significant cell toxicity was 
observed in COS-7 and MEF cells co-incubated with bGO/Mb as measured by IDH activity even 
at very high concentrations. 
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salt) as a chromogen. WST-8 is a water soluble, cell-permeable dye, which gets reduced by the 
active intracellular dehydrogenases (IDH) in the cell cytosol.35 Quantitative reduction of WST-8 
by IDH enables accurate quantification of the overall metabolic health of a living cell.  
The native GO showed significant cell damage after being co-incubated with COS-7 cells 
for 8 hrs at a 25 µg/mL dose resulting in 41 % specific cell death as measured by trypan blue assay, 
significant cell shrinkage and cell cycle arrest (Figure 2-26c; Table 2-3), and ~ 60 % drop in IDH 
activity (Figure 2-26d). In contrast, no sign of cell toxicity was observed for bGO/Mb co-
incubated with COS-7 cells for 48 hrs at a dose as high as 1600 µg/mL with no statistically 
significant change in live/dead cell ratio (Figure 2-26b; Table 2-3) or IDH activity compared to 
control cells (Figure 2-26e). These results suggests that native GO causes serious toxic effects and 
the metabolic health of live cells and should not be used directly in contact with human cells.36 On 
the other hand, bGO/Mb was compatible with cells even at very high concentrations with little 
change in toxicity or metabolic health of cells at doses 160 times higher than those used in the 
bECs (Figure 2-26b and e; Table 2-3). Results suggest that bGO/Mb is safe for living cells, and 
can be used for fabricating implantable packageless bECs working in open cell solution or 
encapsulated bECs.  
Table 2-3. COS-7 cell toxicity data after respective maximum incubation time 
Trial Time of 
Trypan 
Blue 
Assay 
Seeding 
Density 
x 106 cells 
Confluent 
 Density 
x 106 cells 
 
Dead cells  
Observed 
 
% Specific 
cell death  
 
 
Control  
 
48 hrs 0.05 ±  
0.004 
0.22 ±  
0.015 
1850 ±  
115 
0.925 
bGO/Mb 
1600 g/mL 
48 hrs 0.05 ±  
0.003 
0.21 ±  
0.018 
2300 ±  
207 
1.20 
GO  
(25g/mL) 
8 hrs 0.10 ±  
0.008 
0.09 ±  
0.007 
40000 ±  
2500 
44.44  
% Specific Cell death = [Number of dead cells /Total number of cells] x 100 
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Performance and toxicity of the packageless brGO/Mb bECs were evaluated in cell cultures 
of MEF and COS-7 cells in Dulbecco's modified Eagle medium (DMEM) while these bECs were 
subject to continuous cycling test. brGO/Mb bECs were placed in the culture medium with cells 
previously grown in 6-well plates (Figure 2-27a). The packageless bEC was capable of utilizing 
ions in the cell culture medium for charging and discharging (Figure 2-27b-c). CVs at different 
scan rates showed nearly rectangular shapes up to 500 mV/s indicating almost ideal capacitive 
behavior (Figure 2-27d). The toxicity of the brGO/Mb bEC was tested by charging and 
discharging the packageless device in a MEF and COS-7 cell medium for 5000 cycles at high 
current density for 3 hrs. No change in cell morphology or dead/live cell ratio was found due to 
the cycling test, indicating no toxic effects on live cells on short term as measured by the trypan 
blue assay (Figure 2-27e-f; and Figure 2-28). The cell viability after the charge-discharge 
regimen was found to be identical and no significant differences with respect to the control cell 
population (p<0.01, paired student's t-test).   
56 
 
 
Figure 2-27. Performance of brGO/Mb supercapacitor in cell culture medium. (a) Photograph of 
bEC device dipped in 6-well plate containing MEF cells in DMEM, and connected to the 
electrochemical workstation via copper tape. (b) Scheme showing movement of the ions available 
in cell culture medium during charging process. (c) Charge/discharge cycles at different current 
densities in the cell media. (d) CV curves at different scan rates in cell media. (e) and (f) Optical 
microscopy images for MEF cells stained with trypan blue subjected to zero and 5000 
charge/discharge cycles respectively of the packageless bEC for 3 hours. Both (e) and (f) show 
live cells appeared with a very small number of dead cells (stained blue-green, black arrows show 
examples). The absence of differences suggests insignificant cell death due to brGO/Mb bEC 
operation in the cell culture (scale bar is 50 m). (g) & (h) Optical microscopy images for COS-7 
cells stained with trypan blue. (g) Control cells with zero charge/discharge cycles. (h) Cells 
subjected to long term cycling test of the polydimethylsiloxane (PDMS)-packaged bEC for 96 
hours (~90K cycles), showing no difference in cell death as compared to control cells. 
 
The brGO/Mb in a packageless platform make the bEC devices ultrathin, light weight, and 
completely flexible. However, before using the packageless platform of the bEC device in any 
long-term implantable applications, the stability of the device components have to be evaluated 
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for long-term use. The long term stability of the brGO/Mb electrode was evaluated using QCM 
after the film was exposed to 96 hrs of continuous charge and discharge cycles in water (50 mM 
NaCl was added to provide ions for the charge discharge process) in open cell solution. Results 
show a small decrease in the mass of the film from 5.0 g/cm2 to 4.7 g/cm2 which indicate a 
stable brGO/Mb electrodes. However, the PVA separator of the packageless sandwich device 
showed limited stability in open cell solution, and started to break and diffuse into the surrounding 
solution after only 27 hrs. Thus, PVA is not a suitable separator for the long term cycling of the 
packageless bECs in open cell solution, and more research is needed to develop more stable 
separators for long term use.   
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We then evaluated encapsulating the brGO/Mb device in polydimethylsiloxane (PDMS). 
The PDMS was chosen as a packaging material because of its low toxicity, flexibility, and light 
weight.37 bECs showed the exact electrochemical behavior with and without PDMS packaging 
while maintaining complete flexibility (Figure 2-29d). Moreover, the PVA separator remained 
intact throughout the long-term cycling of the PDMS-packaged bECs for 4 continuous days (90192 
cycles) while the bEC was immersed in COS-7 cell culture medium. Cycling for four days 
provided enough time for the cells to make two full cycles of cell division. During the entire 
Figure 2-28. Trypan blue exclusion test of COS-7 
cells subjected to brGO/Mb packageless 
supercapacitor cycling test with different number 
of charge-discharge cycles. Images show mainly live 
cells with the few dead cells stained in blue. (a) 
Control COS-7 cells were not subjected to the device, 
showing 8 ± 4 dead cells. A few dead cells normally 
appeared during the cell culture preparation, and before 
testing the device. (b) COS-7 cells subjected to 5000 
cycles with no significant difference in the number of 
dead cells compared to the control. (c) COS-7 cells 
subjected to 10,000 cycles with nearly equal number of 
dead cells as the control. Scale bar = 50 µm, black 
arrows show examples of dead cells in all images. 
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charging-discharging process, the growing cells were monitored by optical microscopy and no 
perceptible difference in the cell multiplication and overall morphology was found between control 
and bEC test cells (Figure 2-29g-h). No perceptible difference in the overall IDH metabolic 
activity was found between control cells and the cells subjected to continuous charging and 
discharging for 96 hrs. Results clearly show that PDMS device packaging is very efficient in 
maintaining the integrity of performance with no toxic effects on cells, In addition, the drop in the 
areal capacitance after cycling the device for 96 hours was only 11 %. These results suggest that 
brGO/Mb devices could work efficiently as implantable power sources in packageless platform 
for short-term and for long term in PDMS-encapsulated design with good stability. 
2-4.5. Flexibility and Packaging of Biosupercapacitors  
 
Figure 2-29. CVs of brGO/Mb bEC showing (a) the effect of bending the device to different angles, (b) the 
effect of charging/discharging the device to different number of cycles while the device is bent to an angle 
of 90o, (c) the effect of manually bending the brGO/Mb device to different bending cycles. The device was 
bent to an angle of 90o in each cycle. (d) The electrochemical performance of the brGO/Mb bEC in 
packageless and PDMS-packaged platforms bent to a 90 o angle. 
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 Since implantable bioelectronics are always subject to movement inside the patient’s body, 
brGO/Mb bEC performance was evaluated at different bending conditions (Figure 2-29). The 
ultrathin brGO/Mb bEC showed excellent tolerance for bending to different angles (Figure 2-29a) 
with no change in capacitance even after bending to 180o. However, a slight decrease in 
capacitance was observed when the device was subjected to 1000 charge/discharge cycles while 
bent at 90o (Figure 2-29b). In addition, the brGO/Mb device showed no loss of performance after 
bending to 1000 bending cycles to an angle of 90o (Figure 2-29c). These results suggest that the 
brGO/Mb bECs are robust under bending stresses in both packaged and packageless designs which 
make these bEC suitable for the different bending conditions expected for implantable 
bioelectronics.   
Figure 2-30. Electrochemical impedance spectroscopy (EIS) for a brGO/Mb supercapacitor 
in biofluids as well as in an acid electrolyte. (a) A Nyquist plot with the high frequency region 
magnified in the inset shows nearly identical impedance behavior for the device in different 
electrolytes. The brGO/Mb EC exhibited low series resistance in acid (4 Ω) compared with 
biofluids (8-10 Ω). (b) Change of the phase angle with frequency, the time constant () was 
calculated from the frequency (f) at an angle of -450 according to the following relation: () in 
seconds = 1/f (Hz) at -450. Inset shows LED powered by three brGO/Mb ECs connected in series 
with calf serum saturated separators. 
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Electrochemical impedance spectroscopy showed nearly straight lines in the high 
frequency region in all tested electrolytes (Figure 2-30a). The brGO/Mb device showed multiple-
time-constants behavior with cell time constant of only 1.5 ms in biofluids at a frequency of -45o 
(Figure 2-30b). In addition, the down turn of the phase angle at low frequency (< 1 Hz) is mainly 
due to the leakage current/voltage from the packageless devices. Three packageless bECs made up 
of the ultrathin brGO/Mb films were yet capable of efficiently powering a light emitting diode 
utilizing calf serum as the electrolyte (Figure 2-30). On the other hand, the rapid performance of 
our devices is likely to be related to fast ion movement through our thin electrode assemblies with 
myoglobin possibly acting as a nanochannel for fast ion transport.38  
 
2-5. SUMMARY 
 
In summary, novel brGO-protein bECs were fabricated with high volumetric capacitances 
up to 655 F/cm3 in biofluids. Proteins bound to GO sheets played multiple roles in fabricating safe 
and high performance bECs. Firstly, proteins rendered the GO sheets nontoxic to cell-containing 
environments even at high concentrations. Moreover, proteins provide pseudocapacitive behavior 
for charge/discharge through their heteroatom rich nanostructures and the high abundance of the 
protonable charged amino acid residues. Finally, proteins layers provide nanopores that may act 
as nanochannels for shuttling ions in the biofluids to the conductive graphene interlayers. These 
new devices retained high energy density comparable to that of Li thin film batteries while utilizing 
serum/urine or cell media as electrolytes to power LEDs with little loss of performance, and no 
cell toxicity after 5000 cycles in packageless platform and ~ 90K cycles in PDMS-packaged 
design. Unlike batteries which suffer from relatively slow discharge rates, the ultrathin brGO/Mb 
bECs have much faster performance making these devices perfect for the fast discharge of 
electrical signals. With protein as a major component and utilizing body fluids for electrolyte 
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function, these devices have the potential to power the next generation of miniaturized 
bioelectronics. 
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CHAPTER 3 
 
All 3-D Printed Protein Immunoarrys Powered by Supercapacitors. 
 
3-1. ABSTRACT 
 
Herein we report a low cost, sensitive, supercapacitor-powered electrochemiluminescent (ECL) 
protein immunoarray fabricated by an inexpensive 3-dimensional (3D) printer. The immunosensor 
detects three cancer biomarker proteins in serum in 35 min. The 3D-printed device employs hand 
screen printed carbon sensors with gravity flow for sample and reagent delivery and washing. Prostate 
cancer biomarker proteins prostate specific antigen (PSA), prostate specific membrane antigen 
(PSMA) and platelet factor-4 (PF-4 ) in serum were captured on the antibody-coated carbon sensors 
followed by delivery of detection-antibody-coated Ru(bpy)3
2+ (RuBPY)-doped silica nanoparticles in 
a sandwich immunoassay. ECL light was initiated from RuBPY in the silica nanoparticles by 
electrochemical oxidation with tripropylamine (TPrA) co-reactant using supercapacitor power, and 
ECL was captured with a CCD camera. The supercapacitor was rapidly photo-recharged before assays 
using an inexpensive solar cell. Detection limits were 300-500 fg mL-1 for the 3 proteins in undiluted 
calf serum. Assays of 6 patient serum samples gave good correlation with conventional single protein 
ELISAs. This technology could provide sensitive onsite cancer diagnostic tests in resource limited 
settings with the need for only moderate-level training. 
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3-2. INTRODUCTION 
The recent emergence of inexpensive 3D printers offers revolutionary low cost options for 
designing and constructing biosensor systems.1 Fabrication of microfluidic devices by 3D printing 
has been explored for rapid prototyping. Early applications included a master for faster production of 
microfluidic channels from PDMS,2 and reaction ware for chemical synthesis and spectroscopic 
analysis.3 Flow injection systems for monitoring metal ions,4 and add-on accessories for turning 
smartphones into sensors for food allergens and albumin have been printed.5 Milli- and microfluidic 
devices have been printed for nanoparticle synthesis.6 Other applications include calorimetry,7 cell 
growth monitoring with drug transport,8 blood evaluation,9 and pathogenic bacteria detection.10 
Electrochemical sensing integrated into a 3D-printed fluidic device was used to detect dopamine and 
nitric oxide.11 We recently reported a 3D-printed microfluidic amperometric sensor for hydrogen 
peroxide.12 
Microfluidic arrays integrating complex procedures into simple, portable, inexpensive diagnostic 
platforms will be valuable for future personalized healthcare.13 Detection of biomarker panels holds 
great promise for early cancer detection and monitoring,14 and promise to lead to improved 
therapeutic outcomes.15  Ideally, widespread clinical applications will require low cost, low tech, 
multiplexed assay devices.14b, 16 Sensitive, fast, accurate multiplexed protein detection has been 
achieved using conventionally fabricated microfluidic arrays integrated with nanoscale materials.14b-
d, 17 
 Microfluidic array devices are often made using lithography,18 but prototype development time 
and cost can be limiting factors. Injection molding can also be used, but both approaches require 
economies of scale to become cost effective.19 We have developed microfluidic arrays for multiple 
biomarker detection using molded or precision cut microfluidic channels. We coupled amperometric 
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detection on gold nanostructured sensor arrays with magnetic particles massively loaded with enzyme 
labels and antibodies, and demonstrated simultaneous ultrasensitive detection of up to four cancer 
biomarker proteins.20 We also developed electrochemiluminescent (ECL) arrays with antibody-
coated Ru(bpy)3
2+ (RuBPY)-doped silica nanoparticles for detection on single wall carbon nanotube 
forests patterned on pyrolytic graphite chips.21 Both approaches utilized non-lithographic fabrication 
to achieve ultrasensitive detection of multiple proteins in short assays (~35 min). Nevertheless, 
decreasing the time and cost of prototyping and optimizing such devices may lead to benefits in faster 
translation to public health care.22 
Electronically simple, miniature power sources are also important for clinical immunoarray 
development. Small supercapacitors, high performance electrochemical capacitors (EC) that store 
electrical energy,23 have not been widely explored for powering sensors. They have unique 
advantages including high power density, multiple cycling capability,24 and fast charge-discharge 
rates.25 There are a few reports of integrating supercapacitors into analytical systems for signal 
amplification,26 but no examples of powering biosensors.  
Herein we report a 3D-printed, gravity flow microfluidic immunoarray for multiple protein 
detection. These arrays are powered by an inexpensive light-rechargeable supercapacitor costing $12 
that supplies voltage to screen-printed carbon electrodes for electrochemiluminescence (ECL) light 
generation that is detected by a CCD camera. Simultaneous measurement of prostate cancer 
biomarkers, prostate specific antigen (PSA),27 prostate specific membrane antigen (PSMA) and 
platelet factor-4 (PF-4)20a  was achieved at clinically relevant detection limits 0.3-0.5 pg mL-1. To our 
knowledge, this is the first 3D printed microfluidic immunosensor, and first application of 
supercapacitors to a voltage-driven biosensor. Assays of human serum from cancer patients and 
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cancer-free controls gave good correlations to single-protein enzyme-linked immunosorbent assays 
(ELISA).  
3-3. EXPERIMENTAL SECTION 
3-3.1. Chemicals & Materials 
Polylactic acid (PLA) filaments, 1.75 mm diameter for 3D printing were from MakerBot. Carbon 
graphite (C2050106D7) and silver/silver chloride inks (C2051014P10) were from Gwent Electronics. 
Poly(diallyldimethylammoniumchloride) (PDDA), poly(acrylic acid) (PAA), bovine serum albumin 
(BSA), 1-(3-(Dimethylamino)propyl)-3-ethylcarbodiimidehydrochloride (EDC) and N-
hydroxysulfosuccinimide (NHSS) were from Sigma. Pooled human serum samples were from Capital 
Biosciences and individual patient serum samples were provided by George Washington University 
Hospital. ELISA kits for PSA (RAB0331) and PF-4 (RAB0402) were from Sigma Aldrich. The 
PSMA kit (EL008782HU-96) was from Lifeome Biolabs/Cusabio. Immunoassays were done in 
phosphate buffered saline (PBS) pH 7.2. Calf serum as a surrogate for human serum28 was used for 
all calibrations with standard proteins. See supporting information (SI) file for complete experimental 
details. 
3-3.2. Array Device Fabrication  
A commercial desktop 3D Fused Deposition Modeling (FDM or Fused Filament Fabrication, 
FFF) printer, MakerBot Replicator 2X, was used. The microfluidic immunoarray was printed from 
polylactic acid (PLA) (Martin et al., 2001). Initially, a computer-aided design (CAD) was created 
with 123D Design (Autodesk), and converted to 3D printer format using splicing software. Optimized 
printer settings are crucial for good resolution and reproducibility. The heated platform was set to 
60ºC and extruder temperature was 230ºC, with layer height 200 µm. Extruder speed while travelling 
was optimized at 80 mm/s, whereas speed while extruding was 40 mm/s. 
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Figure 3-1A shows the main array printed with 40 mm length x 30 mm width of the base. It has 
three reservoirs or reagent chambers connected to a common downstream microfluidic channel. The 
volume of the reagent chambers is 170 ± 5 µL and the volume required for the microfluidic channel 
to fill completely is 160 µL. Reservoir volumes were chosen to completely fill the detection channel 
in a horizontal position under hydrostatic pressure. The reservoirs are prefilled with sample or 
reagents through port holes located in custom fit 3D-printed inserts (Figure 3-1A) with rods that seal 
the outlets of the reservoirs. Flow of sample and reagents is controlled by placing the insert to seal 
the reservoir, or removing it to drain the reservoir into the detection channel in a horizontal position. 
All reagents are prefilled on the array, and the operator needs only to release reagents sequentially by 
removing the inserts. 
Figure 3-1B shows the add-on wash reservoir designed to work with a lever-assisted moving 
platform device that accommodates the sensor array, wash reservoirs and a waste collector at the 
bottom. The wash reservoir was designed to align with reagent reservoirs of the main array, and is 68 
mm length x 44 mm width x 26 mm height with capacity of ~1.6 mL buffer. Wash buffer in these 
reservoirs is used to wash off excess sample or reagent from the main array microfluidic channels 
after the immunoassay. Wash reservoirs employ custom fit inserts to turn flow on and off similar to 
the reagent chambers. Normal load position has the detection channel with the sensors horizontal. 
Changing the lever on the wash reservoir to wash position provides a 25º tilt angle to the sensor array 
(Figure 3-1B), which enables washing the immunoreagents to a waste chamber at the bottom of the 
detection channel.  
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Figure 3-1. 3D printed main array and wash reservoirs module. (A) Main array showing three reagent 
reservoirs equipped with inserts along with flow path for reagents to reach microfluidic channel. (B) 
Wash reservoir module (1B Left) 3D model showing freely moving lever to change between wash 
and load position along with wash reservoirs aligned with main array, (1B Right) assembled 
immunoarray setup with both main array and wash module. 
 
The sensor electrodes were fabricated by hand screen printing carbon graphitic ink using a 
patterned adhesive-backed vinyl mask template.29 First, a mask template was designed using 
AutoCAD and converted to compatible format for cutting, then a vinyl mask was cut using a portable 
precision desktop cutter (Cameo®, Silhouette America, Inc.). A vinyl sheet was patterned with a 
common working electrode and a counter electrode. Then, this vinyl mask was transferred onto heat 
resistant transparency film (Highland TM 707 clear film), and screen printing was done by spreading 
a thin layer of carbon graphitic ink evenly over the patterned surface, followed by heating at 90ºC for 
15 min. Subsequently, the adhesive vinyl mask was removed revealing the patterned screen printed 
electrodes (Figure 3-2A). A patterned 100 µm thick lamination film with holes revealing the 
electrodes was also made by precision cutting. These lamination films were sealed onto the pattern 
of electrodes in a heat press at 110ºC, creating hydrophobic microwells around the sensors that hold 
up to 5µL of aqueous solution (Figure 3-2B). Lastly, a template was patterned from transparency 
film to print Ag/AgCl paste reference electrode (Figure 3-2B). The laminated, screen-printed sensor 
72 
 
assembly was then attached to the 3D printed immunoarray using silicone glue (Proseal clear RTV 
silicone adhesive sealant), which was dried for at least 2 hr (Figure 3-2C).  
Figure 3-2. Schematic representation of steps for screen printing carbon electrodes and assembling 
the immunoarray. (A) Print and Peel technique to screen print carbon graphitic ink over the vinyl 
electrode template using an ink spreader followed by heating to form solid screen printed electrodes. 
(B) Laminating the exposed electrodes to leave 4 microwells followed by screen printing Ag/AgCl 
reference electrode. (C) Printed electrodes glued to complete immunoarray device. 
 
Supercapacitors (Cellergy, 2.1 V, 80 mF) used to power ECL arrays were low equivalent series 
resistance (ESR) aqueous state electrolyte, high output electrochemical double layer capacitors 
(EDLC’s). A solar panel (Sparkfun, 0.45 W, 94 mA) was used to charge the supercapacitor to 1.5 V 
under ambient room, sun, or iphone light. Voltage was checked with a digital multimeter prior to 
every experiment to ensure accuracy.  ECL was generated by electrochemical oxidation of both 
tripropylamine (TPrA) and RuBPY on the sensors when 1.5V was applied. This initiates a complex 
redox pathway involving RuBPY in the silica nanoparticle and results in electronically excited 
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[RuBPY]2+* that emits light at 610 nm.30 Generated ECL was captured from the sensor array using a 
CCD camera.21b 
RuBPY-silica nanoparticles (RuBPY-SiNP) with average diameter of 117±10 nm were 
synthesized and characterized as described previously and coated with successive layers of PDDA 
and PAA, followed by covalently linking secondary antibodies to –COOH groups of PAA 31. Three 
different RuBPY-SiNP-Ab2 were prepared featuring anti-PSA, anti-PSMA and anti-PF-4 as Ab2. 
Optimized Ab2 concentrations for attachment onto RuBPY-SiNPs were 8 µg mL
-1 for PSA, and 7.5 
µg mL-1 for PSMA and PF-4. For simultaneous detection of all 3 proteins, the three RuBPY-SiNPs 
were mixed in equal proportions. The Ab2/RuBPY-SiNP ratio was measured at 38:1 (see SI).  TprA 
at 350 mM in 0.2 M phosphate buffer + 0.05% Tween-20 (T20) and 0.05% Triton-X at pH 7.5 was 
used as ECL co-reactant.  
3.3-3 Assay Procedure 
Sensors in the array were coated by layer-by-layer (LbL) deposition of PDDA (2 mg mL-1 in 
water) and PAA (2 mg mL-1 in water) for 20 min, giving estimated layer thickness of 1-2 nm (Lvov 
et al., 1998). Carboxylic groups on the outer PAA layer were activated by freshly prepared 400 mM 
EDC + 100 mM NHSS to immobilize capture antibody (Ab1) by amidization (Malhotra et al., 2010) 
using an optimized  Ab1 concentration of 100 µg mL
-1. Ab1-coated sensors were incubated with 1% 
casein in PBS for 1 hr to minimize non-specific binding (NSB). Reagent chambers on the array were 
prefilled with serum samples, detection antibody (Ab2)-coated RuBPY-SiNP dispersions, and TprA 
solution. Serum samples (2-5 µL) were first diluted 500-fold in calf serum prior to loading.   
Delivery of sample and reagents from prefilled reservoirs of the main array is accomplished by 
removing the insert top. The reagents flow downstream to fill the detection channel. Prefilled wash 
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buffers from wash reservoirs flush the detection channel when the wash module lever is adjusted to 
provide a 25º tilt angle.  
Individual assay steps are: (1) Release sample from its reservoir to fill the detection channel and 
incubate for 20 min (Figure 3-3A) in horizontal load position (Figure 3-3B). This allows analyte 
proteins to be captured on Ab1-coated sensors. (2) Move platform to wash position (25
o tilt) by 
pushing the lever down, then release wash buffer from its reservoir (Figure 3-3C). Buffer from the 
larger wash reservoir passes through the sample reservoir into the detection channel and flushes 
unbound protein to waste (Figure 3-3D). (3) The platform lever is then returned to the load position, 
followed by release of Ab2-RuBPY-SiNPs into the horizontal detection chamber, and incubation for 
15 min is allowed to bind to previously captured proteins. (4) Wash unbound silica nanoparticles to 
waste by placing the lever in wash position. (5) TPrA solution is released from its reservoir into the 
horizontal detection channel, the array is placed under the CCD camera in a dark box, and potential 
of 1.5 V vs. Ag/AgCl is applied with the supercapacitor to generate ECL for 60 s. Acquired ECL 
images are then processed by software to estimate light intensities from each microwell on the array. 
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Figure 3-3. Details of the assay procedure: (A) cartoon showing removal of insert for sample delivery 
from reservoir by gravity flow; (B) load position show with blue food color solution filling the 
horizontal detection channel with lever up; (C) cartoon showing buffer delivery from wash reservoir 
to detection channel for washing away unbound proteins (inset shows sandwich immunoassay on 
sensors); (D) wash position showing blue food color solution delivered from wash reservoir to main 
array when lever is down for 25º tilt of detection channel.  
 
3-4. RESULTS 
3-4.1. Array Characterization & Optimization 
Surface areas of the screen printed electrodes were measured by cyclic voltammetry (CV) of 0.06 
mM methanol (FcMeOH) in 1 M NaCl from 10 mV s-1 to 750 mV s-1 showed a diffusion-controlled, 
one electron reversible oxidation-reduction peak pair with separations 60-67 mV (Figure 3-4A). 
From the slope of peak current (ip) versus square root of scan rate (1/2) using the Randles-Sevcik 
equation,32 and diffusion coefficient 2.5 x 10-7 cm2 s-1, 33 we estimated surface area of the printed 
electrodes was 0.293± 0.015 cm2, RSD ± 5% (n=12). The larger electrochemical area compared to 
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average geometric area 0.071 cm2 is due to the rough, porous nature of the screen printed electrodes. 
Characterization of the supercapacitor was also done by cyclic voltammetry (CV) (Figure 3-4B) and 
by observing galvanostatic charge-discharge cycles (CC) (Figure 3-4C). Results show rectangular 
CVs at scan rates up to 2 V/s, as well as triangular CC curves at current density 30 mA/cm2 indicating 
nearly ideal capacitive behavior under fast charge-discharge conditions.  
3-4.2. Reproducibility & Immunoarray Calibrations 
Reproducibility of array sensors was evaluated at 0 and 500 pg mL-1 for the 3 protein analytes. 
Variation in relative ECL intensities was ≤7% (n=3) array-to-array and ≤10% spot-to-spot (n=9) 
(Figures 3-4D and E). Out of four sensors on the array, sensors 1, 3 and 4 were used for specific 
protein detection. Sensor 2 at the center was used to measure background for each array, and was 
coated with 1% casein but no capture antibody. Figure 3-4F shows the supercapacitor mounted on a 
printed circuit board (PCB), connected to the array inside a dark box to generate ECL. 
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Figure 3-4. Electrochemical characterization of sensors and supercapacitor: (A) Cyclic 
voltammograms of screen printed carbon electrodes with 0.06 mM FcMeOH in 1 M NaCl, showing 
oxidation-reduction reversible peak pair separated by ~60-67 mV at low scan rates ; (B) CV’s for 
supercapacitors up to 2 V s-1 showing nearly ideal electrical double layer capacitance behavior; (C) 
Galvanostatic charge-discharge cycles at current density 30 mA/cm2; (D) Recolorized ECL images 
demonstrating reproducibility between 9 spots across 3 arrays at 0 pg mL-1 PF-4 protein; (E) 
recolorized ECL image demonstrating reproducibility between 9 spots across 3 arrays at 500 pg mL-
1 PF-4; (F) mounted supercapacitor connected to ECL array inside a dark box.  
 
We tested the immunoarrays by determining several proteins simultaneously using mixtures of 3 
proteins standards in undiluted calf serum. (Figure 3-5A) Calibration curves were obtained by 
assigning sensor 1 to detect PSA (Figure 3-5B), 2 to background, 3 to PSMA (Figure 3-5C) and 4 
to PF-4 (Figure 3-5D). Specific capture antibodies (Ab1) were first immobilized on the carbon sensors 
by adding 3 µL of  Ab1 and incubating for 2.5 hours at room temperature followed by adding 1% 
casein and incubated for 1 hour. Then, protein mixtures were introduced onto these sensors, followed 
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by the delivery of multiplexed RuBPY-SiNP ECL labels and development reagents from the prefilled 
chambers.  
Figure 3-5. Calibration data in undiluted calf serum showing influence of biomarker protein 
concentration on ECL response: (A) Recolorized ECL images of 8 arrays with showing increase in 
ECL intensity with increased concentration. ECL signals were integrated over 60 s, for (B) PSA, (C) 
PSMA and (D) PF-4 in calf serum. Error bars show standard deviation for n = 4.  
 
Calibration curves for multiplexed detection were obtained by dividing average ECL signal for each 
concentration by control signals on each sensor chip (n=4). Dynamic ranges were from 500 fg mL-1 
to 10 ng mL-1 for all protiens and detection limits as 3 times the standard deviations of zero protien 
controls were 300 fg mL-1 for PSA, 535 fg mL-1 for PSMA and 420 fg mL-1 for PF-4.  
3-4.3. Assays of Human Serum Samples 
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We measured the analyte protiens from 4 prostate cancer patient serum samples and 2 cancer free 
human samples using the calibration curves in Figure 3-5. ECL immunoassay results correlated well 
with single protein ELISA assays (Figures 3-6A-C). Linear correlation plots obtained for ELISA vs. 
ECL immunoarray data (Figures 3-6D-F) had slopes close to 1.0, i.e. 1.4 ± 0.12 for PSA, 0.77 ± 0.05 
for PSMA and 0.99 ± 0.08 for PF-4. Intercepts of these plots were close to zero, i.e., -1.36 ± 0.68 for 
PSA, 0.008 ± 0.03 for PSMA and 0.002 ± 0.041 for PF-4 consistent with good correlation. 
Figure 3-6. Comparisons of ECL vs. standard ELISA assays on human serum samples. Samples 1-4 
are from prostate cancer patients and 5-6 are from cancer free individuals: (A) PSA (B) PSMA (C) 
PF-4 as bar graphs. Error bars are standard deviations with n=4 for ECL arrays and n=3 for ELISA. 
Bottom row shows linear correlation plots of ECL vs. ELISA validation studies for (D) PSA, (E) 
PSMA and (F) PF-4. 
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3-5. DISCUSSION 
Results above demonstrate successful development of an inexpensive portable 3D printed ECL 
arrays capable of measuring three proteins simultaneously. These arrays use supercapacitors to 
generate ECL, and the full device costs ~€0.90 in materials to fabricate, with a cost of ~0.30 
euros/assay. The platform utilizes simple steps to complete the immunoassay in 35 min without no 
sophisticated equipment except a CCD camera. Detection limits of 300 fg mL-1 for PSA 535 fg mL-1 
for PSMA and 420 fgmL-1 for PF-4 were observed with dynamic ranges of from 500 fg mL-1 to 10 
ng mL-1 (Figure 3-5). These dynamic ranges readily correspond to clinical ranges of these proteins 
in serum after appropriate sample dilutions. 
Accuracy of the ECL immunoarrays was confirmed by correlation to single protein ELISA 
(Figure 3-6). Patient serum samples as low as 5 µL were used at 500-fold undiluted calf serum, used 
here to mimic the possibility of determining very low concentrations of proteins in a full serum matrix. 
This experiments revealed reasonably accurate detection the 3 analyte proteins in the presence of 
thousands of other proteins in the mixed serum media,34 demonstrating the high selectivity of the 
approach. Good correlation between ELISA and our arrays along with relatively low array-to-array 
standard deviations indicates great potential for future clinical applications (Figure 3-6).  
These 3D printed ECL microfluidic arrays produced by a desktop 3D printer shown could serve 
as a simple and inexpensive diagnostic platform. The printed components of the array cost only 
~€0.90 in materials, suggesting applications for both developing and developed economies. The 
sensor module is a disposable platform costing ~€0.20, whereas the reusable wash module costs 
~€0.70. Considering all other costs for immunoreagents, a single immunoassay costs ~€1.20, 
considering the entire platform (€0.9) to be disposable. If the wash module is reused, the average cost 
for per assay decreases to €.50, for three proteins simultaneously detected.  
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Screen printing of the sensors used an inexpensive high precision desktop craft cutter for 
patterning templates for screen printing and lamination. Using adhesive backed patterned vinyl sheets 
for hand screen printing the electrodes provided acceptably reproducible sensor surface areas (±5%) 
by an inexpensive fabrication method. Lamination after printing provides an effective hydrophobic 
boundary when attaching capture antibodies from aqueous solutions. The combination of the 3D 
printed array and screen printed sensors provided ECl repoducibility within ±10% spot-to-spot and 
array-to-array, which is a little larger than desirable for bioanalytical devices. However, 
reproducibility has been compromised somewhat for simplicity and very low cost.  
Supercapacitors coupled with solar panels allowed rapid light-driven charging to 1.5 V between 
assays to drive the ECL generation step. Integration of this small power source on the immunoarray 
helps make it portable by avoiding potentiostatic equipment, and makes the assay simpler for the 
operator. Future coupling our immunosensors with a cell phone digital camera could provide a 
complete onsite cancer detection array for resource limited settings.  
3-6. SUMMARY 
In summary, results demonstrate a new, very low cost, pump free 3D-printed, portable 
immunoarray for sensitive detection of proteins. The system results in ECL-based assays that costs 
only ~€0.50 and can be completed in 35 min. without high level technical expertise. The inexpensive, 
robust and portable supercapacitor (€10 for power storage with a solar panel (€12) for recharging, the 
entire immunoarray costs only ~€25, not including the CCD camera. A drawback of this system, 
however, is that a significant number of tasks must be completed by the operator to achieve the full 
immunoassay. Nevertheless, this work also suggests that 3D-printing can be used to develop more 
sophisticated immunoarray devices with a higher level of automation. 
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CHAPTER 4 
 
3-D printed Microfluidic Pipette Tip Sensor for Genotoxic Chemistry 
Screening Powered by Photorechargable Biosupercapacitor 
 
 
4-1. ABSTRACT 
 
The fabrication and development of fully portable and self-powered DNA damage 
biosensors is crucial for detecting potential genotoxic chemicals and their metabolites presents in 
environmental samples. Herein, we developed a novel, low-cost, portable, and three dimensional 
(3-D) electrochemical microarray on the form of a micropipette tip for genotoxic chemistry 
screening. This electrochemiluminescent (ECL) based sensor is powered by photo-rechargable 
biosupercapacitor fabricated from reduced graphene oxide/myoglobin nanocomposites (rGMb). A 
multilayer film was layer-by-layer assembled on the array to include DNA, microsomal enzymes, 
and ECL-emitting metallopolymer. This self-powered sensor was able to detect low levels of 
Aflatoxin B1 (AFB1) to establish a proof of concept. Onsite environmental sample analysis of 
polluted water is underway. This biosupercapacitor powered sensor provides a new platform of 3-
D printed devices capable of the onsite assessment of the relative DNA damage of environmental 
samples in developing countries and in remote areas.       
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4-2. INTRODUCTION 
There is a pressing need to improve in vitro assessments of possible toxicity risks for humans from 
emerging environmental pollutants and pharmaceutical candidates. Toxic effects related to the damage 
of genetic material (i.e. DNA) are referred to by the term genotoxicity. DNA damage gives rise to 
mutations, and can be a key event in carcinogenesis.1 One of the major categories of DNA damage 
results from the reaction of metabolites or parent compounds with the nucleobases to form so-called 
DNA adducts.2  Reactive metabolites of chemicals can react with DNA nucleobases to form covalently 
linked nucleobase adducts that may be key players in carcinogenesis, and are important biomarkers of 
genotoxicity.3 From one hand, liquid chromatography-mass spectrometry (LC-MS) and other 
approaches can measure DNA adducts,4 protocols most often require hydrolysis of the damaged DNA, 
and may be time consuming and expensive for screening large numbers of new chemicals. On the other 
hand, toxicity prediction tests such as Ames, Comet, and micronucleus assays can provide useful 
information about the toxicity of chemicals, but they suffer from complexity of use, lack of metabolic 
generality, and they require sophisticated instrumentation of running the assay or analyzing the results. 
These limitation of current available tests remain a hurdle for portable onsite sample analysis in 
developing countries and remote areas. Therefore, a low-cost, portable, feasible, and self-powered 
genotoxicity screening sensors are highly needed.  
Herein we report a new array that employs thin films of metabolic enzymes, DNA and catalytic Ru 
metallopolymers to measure metabolite-related DNA damage from adduct formation. This ECL based 
assay is fully driven by a biosupercapacitor which is rapidly charged by a portable solar panel through 
wireless charging feature.   
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4-3. EXPERIMENTAL SECTION  
 
4-3.1. 3-D Printing of Pipette Tip Electrochemical Sensor 
 
The 3-D printed micropipette tip was fabricated using Formlabs Form2 which is stereolithographic 
3-D printer. Using 123D-design software, the model designs were made and converted to the printer 
format files and printed. The resulting printed micropipette tips were then rinsed multiple times with 
isopropanol and pure water. The printed device was then dried and sprayed with a clear acrylic solution. 
The 3-D printed pipette tip was then transformed to a full electrochemical cell by adding working 
graphite as working electrode, Ag/AgCl as a reference electrode, and Pt as a counter electrode (Figure 
4-1). The 3-D printed tip device is designed to fit perfectly in the 50 L micropipette.  
 
 
Figure 4-1. 3D-printed microfluidic micropipette tip sensor. (A) Top and bottom views of the 
micropipette tip. (B-C) Side and top view of the full micropipette tip microfluidic electrochemical 
sensor with intenerated working, counter, and reference electrodes.    
 
4-3.2. Wireless Charging Photo-Biosupercapacitor System 
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First, the wireless system relies on the concept of magnetic induction as demonstrated in 
Figure 4-2. It consists of a wireless transmitter coil and another receiver coil. The light energy 
harvested by the portable solar panel is wirelessly transmitted through the transmitter coil to 
the detection device which consists of a receiver coil, biosupercapacitor, and the micropipette 
tip sensor array.  
 
Figure 4-2. Wireless and photo-rechargeable biosupercapacitor powering the first 
micropipette tip microfluidic electrochemical device.   
 
4-3.3. Rapid and Scalable Synthesis of Graphene-protein Biosupercapacitors as Power 
Sources 
The positively charged protein is added to a solution of negatively charged graphene oxide 
slowly with stirring. This is followed by the introduction of the bare current collector to the 
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solution and the application of -1.1 V vs. SCE which lead to the formation of uniform films of 
thick reduced graphene oxide/protein nanocomposite, for example reduced graphene/myoglobin 
(rGMb). This method lead to thicker films than traditional layer by layer assembly. This improved 
method led to the construction of a high performance biosupercapacitors in 30 seconds fabrication 
time which is scalable and suitable for commercialization. 
4-4. RESULTS & DISCUSSION 
4-4.1. Biosupercapacitor Electrochemical Performance 
The electrochemical performance of the as prepared biosupercapacitor was evaluated in 
calf serum as an electrolyte. Cyclic voltammetry was used to test the biosupercapacitor behavior 
vs. a similar capacitor of the same components but with bare electrodes (no rGMb). At a scan rate 
of 1.0 V/s, the current density of the rGMb is ~ 100 folds higher compared to bare electrodes 
capacitor of the same size. Similarly, the charge/discharge curves of the rGMb biosupercapacitor 
shows an areal capacitance of 2.3 mF/cm2 compared to 25 F/cm2 of the bare electrodes. This 
areal capacitance is higher than the one we previously reported using layer-by-layer (LbL) 
assembly technique. One major advantage of the direct electrochemical deposition over the LbL 
assembly is the ability to form much thicker films in only 30 seconds, while the LbL assembly 
takes few hours to build 30 nm thick film. The fast and thicker films of the rGMb would allow 
further scaling up of the procedure and commercialization.  
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Figure 4-3. Electrochemical characterization of reduced graphene oxide/myoglobin 
nanocomposite (rGMb) based biosupercapacitors. (A-B) Cyclic voltammetry of bare electrode 
(A) and the electrode after the electrochemical deposition of rGMb (B) at a scan rate of 1.0 V/s in 
serum. (C-D) Charge discharge curves of bare (C) and rGMb electrode (D) in serum.  
 
 
 
 
 
 
 
92 
 
4-4.2. Eelectrochemluminescence (ECL) Signal Output  
  
 
Figure 4-4. Genotoxicity screening array. (A) Thin and flexible Panasonic graphite sheet 
patterned with micro wells which retain 1L drops of solutions between their hydrophobic 
boundaries. (B) A scheme showing the metabolite generation and adduct formation on the sensor 
surface driven by a voltage of -0.65 V vs. Ag/AgCl. This is followed by the ECL signal generation 
at 1.25 V vs. Ag/AgCl. Adapted from reference 5. Both electrochemical reactions are driven by 
the wireless and photo-rechargeable biosupercapacitor. (C-D) ECL recolonized images showing 
the effect of different aflatoxin-1 (AFB-1) concentration on DNA damage which is detected in 
terms of ECL signal increase driven by the photorechargable biosupercapacitors. (E) Metabolic 
activation of Aflatoxin B1 (AFB1) to it’s epoxide form followed by a subsequent covalent DNA 
adduct. 
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In order to build the sensor film, LbL assembly of human liver microsome enzyme (HLM), 
DNA, and RuPVP light emitting metallopolymer 6. These layers were assembled on the microwells 
of the array as shown in Figure 4-4A. The detection og the reaction genotoxicity involves two 
main steps. First, the Cytchrome P450 (Cyt p450) natural cycle is activated by applying -0.65 V 
vs. Ag/AgCl while flowing the oxygenated test compound in suitable buffer for 45 seconds. This 
process lead to the formation of the compound metabolite which further react with the DNA. 
Second, the ECL generation step start after washing the array with buffer and apply +1.25V vs. 
Ag/AgCl for 3 mins which generates ECL signal which is directly proportional to the damage of 
DNA. Both voltages were applied through a portable, wirelessly charged biosupercapacitor which 
replaces the bulky electrochemical workstation. 
For a proof of concept, Aflatoxin B1 (AFB1) was used in this study as a text compound. 
Previous results have shown that AFB1 metabolite induces DNA damage.7 The ECL results of 
different concentrations of AFB1 were obtained and decolorized images and the corrosponding 
standard curve were generated (Figure 4-4). The micropipette sensor was able to detect low 
concertation of AFB1 in buffer sample and real water sample is planned. 
4-6. SUMMARY 
 
We fabricated the first fully biocompatible and wirelessly photo-rechargeable 
biosupercapacitor from the reduced graphene oxide/myoglobin nanocomposite. This small and 
flexible biosupercapacitor was able to activate Cyt P450 enzyme and also produce the ECL signal 
indicative of the DNA damage caused by AFB1. The use of 3-D printed micropipette tip as a 
sensor allowed portability and low cost genotoxicity sensing.  
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CHAPTER 5 
 
Noble Metal-Free Electrocatalysts for Electrochemical Energy Conversion 
 
5-1. ABSTRACT    
Understanding the origin of manganese oxide activity for oxygen reduction reaction (ORR) and 
oxygen evolution reaction (OER) is a key step towards rationally designing of highly active 
catalysts capable of competing with the widely used, state-of-art noble metal catalysts. Herein, we 
present a bifunctional, thermally stable cesium-promoted mesoporous manganese oxide (Cs-
MnOx) tuned by simple heat treatment from an amorphous to a crystalline phase with controlled 
surface and bulk active Mn centers. The Cs-MnOx material exhibited the highest ORR activity 
(0.87 V vs. RHE at -3 mA/cm2) among all noble-metal-free manganese oxide catalysts reported to 
date with superior activity compared to state-of-the-art Pt/C catalyst. In addition, Cs-MnOx 
exhibited comparable OER performance with the highly active Ir/C and RuO2 catalysts. Extensive 
characterization and density functional theory (DFT) computations suggested that the stabilization 
of the surface and bulk enriched Mn3+ species, increase of relative basicity and maintaining active 
crystalline phase due to Cs incorporation, are the main decisive factors for the profound ORR and 
OER activities. Findings from our study provide general guidance for designing of cost effective 
and active metal oxide based electrocatalysts. 
 
 
96 
 
5-2. INTRODUCTION    
Recent and impending global energy crises have stimulated extensive research efforts in 
renewable energy production and storage.1 In particular, the oxygen reduction reaction (ORR) and 
oxygen evolution reaction (OER) are of great interest due to their importance with respect to a 
number of energy conversion applications, including fuel cells and water splitting systems.2 
Bifunctional OER and ORR catalysts are of special significance for energy storage in rechargeable 
metal-air batteries, where both reactions happen at the cathode during charging and discharging 
processes.3 One of the difficulties associated with ORR and OER is their sluggish reaction kinetics, 
which results in low system efficiency. Precious metals like platinum (for ORR) and oxides of 
iridium or ruthenium (for OER) are considered state-of-art catalysts achieving very high catalytic 
activity.4 The high cost, scarcity, and relatively low stability of precious metals for ORR and OER 
have resulted in great interest in the development of alternative bifunctional electrocatalysts that 
are efficient, cost-effective and robust.5  
Among non-precious metal oxides, manganese oxides are especially attractive as 
electrocatalysts due to their natural abundance, low toxicity, multivalent nature and structural 
diversity (more than 30 crystal structures corresponding to different polymorphs are known to 
exist).6 Manganese oxides have also inspired great interest as catalysts for water oxidation due to 
the natural presence of the highly OER active CaMn4Ox cluster in the oxygen evolving complex 
(OEC) of Photosystem II involved in photosynthesis.7 Several types of manganese oxide catalysts 
(rutile, spinel, peroxide, tunnel, birnessite) have been used as water oxidation and oxygen 
reduction catalysts in alkaline media.8 However, the documented ORR and OER activities are still 
low compared with the state-of-art Pt-, Ru-, or Ir-based catalysts which hinder their use in real-
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world applications. Extensive studies have been made on the structure-property relationship of 
different Mn oxides with the aim of enhancing their catalytic activity.9  
The rational design of active ORR and OER manganese oxide catalysts require choosing 
the active manganese oxide phase (crystalline or amorphous), active Mn oxidation state, 
optimization of surface and bulk Mn centers, as well as high surface area. Towards that end, 
researchers have used mesoporous materials as active electrocatalysts due to their high surface 
area, and tunable porous structure.10 Attempts have been made to tune the Mn oxidation state by 
introducing different elements to manganese oxide catalysts. Incorporation of Au nanoparticles in 
Mn oxide was found to promote the formation of surface-active Mn3+ species, which resulted in a 
significant enhancement in water oxidation activity over typical Mn oxides11. Alkaline earth metals 
are also known to influence the catalytic activity of manganese oxides12. 
Herein, we document a bifunctional Cs ion-promoted mesoporous manganese oxide (Cs-
MnOx) synthesized by a facile soft-templated inverse micelle approach for ORR and OER.
13 The 
material exhibited aggregated nanocrystalline nature with tunable mesoporous size. Simple heat 
treatment of Cs-MnOx enabled precise control over surface and bulk active Mn
3+ species, pore 
size, surface area, and crystallinity, making this mesoporous material well-suited for investigating 
the origin of manganese oxide activity for ORR and OER.  Cs-MnOx calcined at 450 
oC (Cs-MnOx-
450) outperformed other reported noble-metal free manganese oxide catalysts for ORR and also 
exhibited a very high activity in OER, achieving the smallest difference in potential between ORR 
(at -3 mA/cm2) and OER (at 10 mA/cm2) among all manganese oxide catalysts reported (0.78 V). 
Moreover, the ORR activity of Cs-MnOx-450 was higher than the state-of-art Pt/C catalysts with 
faster electron transfer rate. In the case of OER, the activity was lower than the highly active Ir/C 
and RuO2 catalysts at low current density, but higher at high current density with 4 fold higher 
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stability. Physical and electrochemical studies supported by theoretical validation confirmed the 
critical roles of surface and bulk-enriched Mn3+, stabilization of active crystalline phase, and high 
surface area in the superior electrocatalytic behavior or Cs-MnOx.  
5-3. EXPERIMENTAL SECTION 
5-3.1. Catalyst Synthesis Protocol 
(a) Synthesis of Cs-MnOx: The synthesis followed our recent published article.19 In a typical 
synthesis manganese nitrate tetrahydrate (Mn(NO3)2.4H2O. 0.02 mol)  and 1-butanol (0.134 mol) 
were added into a 120 mL beaker. To this solution Poly(ethylene glycol)-block-poly(propylene 
glycol)-block-poly(ethylene glycol) (0.0034 mol) (Pluoronic P123, PEO20PPO70PEO20, molar 
mass 5750 g mol-1) and concentrated nitric acid (0.032 mol) (HNO3) were added and stirred at 
room temperature until the solution became clear (light pink). To this clear solution 200 µL of 
1.0M CsNO3 was added maintaining the Mn/Cs ratio 100/1, mol/mol. The resulting clear solution 
was then kept in an oven at 120 °C for 3 h under air. The black material was washed with excess 
ethanol, centrifuged, and dried in a vacuum oven overnight. The dried black powders were 
subjected to a heating cycle. First they were heated at 150 °C for 12 h and cooled down to room 
temperature under ambient conditions followed by heating steps of 250 °C for 3 h, 350 °C for 2 h, 
450 °C for 1 h, 550 °C  for 1h, and 650 °C for 1 h.  
(b) Synthesis of MnOx: Synthesis of the non-promoted MnOx followed the same procedure of 
the Cs-MnOx, but without addition of any Cs precursor.  
* It is recommended to perform all reactions in ovens with proper ventilation due to release of 
toxic NOx from the gel during the reaction. 
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5-3.2. Electrochemical Characterizations: 
Electrocatalytic performance of all studied catalysts towards oxygen reduction reaction 
(ORR), and oxygen evolution reaction (OER) was characterized on three electrode electrochemical 
cell connected to CHI 660A electrochemical workstation. Cyclic voltammetry (CV), linear sweep 
voltammetry (LSV), electrochemical impedance spectroscopy (EIS), chronopotentiometry, and 
chronoamperometry were performed in 0.1 M KOH purged with high purity oxygen or argon for 
30 min before start running the electrochemical measurement, with flowing the gas over the 
solution surface during the data collection. Standard calomel electrode (SCE) was used as 
reference electrode, while pyrolytic graphite was used as both working and counter electrodes. 
5-3.3. Electrode Preparation: 
Pyrolytic graphite (PG) electrode was polished using silicon carbide grinding paper before 
sonicating in ethanol and water (2 min each) to produce clean, and smooth PG surface. The catalyst 
ink was prepared by mixing 4 mg of catalyst, 1 mg of carbon black, and 85 L Nafion in 1.0 mL 
of DI water/ethanol mixture (4:1). The catalyst ink was sonicated for 5 min to ensure proper mixing 
of the component, and then loaded to the rotating disc PG electrode (mass loading 0.28 mg/cm2) 
by controlled drop casting method. The catalyst ink was incubated on the PG surface overnight in 
room temperature before running electrochemical measurements. 
5-3.4. Calculations of Activity Parameters: 
Koutecky-Levich (K-L) plots were studied to interpret the ORR results. The number of 
electron transferred per one oxygen molecule (n) can be obtained from K-L plots by applying the 
following equations:  
KKL JBJJJ
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Where, J is the measured current density, JK is the kinetic current, JL is the diffusion limiting 
current, ω is the rotation speed of the electrode in rad s-1, B is the reciprocal of the slope of the K-
L plots, F is Faraday constant (96485 C mol-1), CO is the saturated concentration of oxygen in 0.1 
M KOH (1.2 x 10-6 mol cm-3), DO is the diffusion coefficient of O2 (1.9 x 10
-5 cm2 s-1), 𝝂 is 
kinematic viscosity of the electrolyte (0.01 cm2 s-1), k is electron transfer rate constant for the 
ORR. 
Calculation of mass activity and turn over frequency (TOF): 
M
j
ActivityMass   
Where j is the current density in A/cm2, while M is the mass of the loaded catalyst in grams. TOF 
(s-1) was calculated according to the following formula: 
 
nF
jA
TOF
4
   
Where j is the current density (A/cm2), A is working electrode surface area (cm2), n is the number 
of moles of the loaded catalyst onto the working electrode, and F is the Faraday constant (C mol-
1). 
Calculations of standard rate constant (ko) 
Using the charge transfer resistance (Rct) obtained from the EIS data, k
o was calculated using the 
following formulas: 
𝐽0 =
𝑖0
𝐴
= 
R T
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Where J0 is the exchange current density, i0 is the exchange current, A is the electrode surface area, 
R is the gas constant, T is the absolute temperature, n is the number of electrons transferred 
(assumed to be 4 in both ORR and OER for all catalyst for comparison), F is Faraday’s constant, 
C is the saturated concentration of oxygen in 0.1 M KOH. 
5-4. RESULTS 
 
Figure 5-1. Comparison of the best optimized Cs-MnOx-450 to commercial and state-of-art 
catalysts. (A) FE-SEM. (B) AFM with magnification in (C) showing a mean surface roughness 
(Ra) of 22 ± 3 nm. Ra is defined as the average surface height deviations measured from the mean 
plane within a selected area of 1 m2. (D) TEM image showing the lattice distances of 0.27 nm 
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which are indexed to bixbyite Mn2O3 (222) planes. (E) PXRD, (F) N2 sorption, (G) Linear sweep 
voltammetry (LSV) curves for ORR, and (H) LSV curves for OER. 
The physicochemical and morphological features of Cs-MnOx catalysts were extensively 
characterized by powder X-ray diffraction (PXRD), N2 sorption, scanning electron microscopy 
(SEM), X-ray photoelectron spectroscopy (XPS), X-ray absorption near-edge spectra (XANES), 
extended X-ray absorption fine structure (EXAFS), transmission electron microscopy (TEM), 
atomic force microscopy (AFM) and inductive coupled plasma - mass spectrometry (ICP-MS). 
The morphology of the Cs-MnOx material calcined at 450 °C (highest activity for ORR and OER 
among all calcination temperatures) was investigated using SEM, TEM, and AFM (Figure 5-1A-
D). The field-emission scanning electron microscopy (FE-SEM) image of Cs-MnOx-450 (Figure 
5-1A) showed aggregated round shaped nanoparticles. Tapping mode AFM was used for exploring 
the surface of the Cs-MnOx-450, and the surface roughness was analyzed to be 22 ± 3 nm, 
providing a nearly uniform rough catalytic surface for the reactions (Figure 5-1B-C). The TEM 
image of Cs-MnOx-450 revealed the crystalline nature of the material with a measured lattice 
spacing of 0.27 nm that was assigned to the (222) planes of Mn2O3 (bixbyite) phase (Figure 5-
1D). Figure 5-1E showed the wide angle (5° - 75°) powder X-ray diffraction (PXRD) patterns of 
Cs-MnOx-450 and commercial Mn2O3, which confirmed  the crystalline Mn2O3 (bixbyite) phase 
of Cs-MnOx. In addition, the Cs-MnOx-450 material possessed a Type IV adsorption isotherm 
followed by a hysteresis loop (indication of regular mesoporous structure) as obtained by the N2 
sorption measurements, whereas the isotherm nature of commercial Mn2O3 confirmed the 
nonporous structure. (Figure 5-1F). The exceptional electrochemical properties of mesoporous 
Cs-MnOx-450 compare to commercial Mn2O3, Pt/C, Ir/C and RuO2 towards ORR and OER are 
shown in Figure 5-1G-H. The mesoporous Cs-MnOx-450 displayed much higher activity 
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compared to the commercial nonporous Mn2O3. Moreover, the ORR performance of the Cs-MnOx-
450 outperformed the state-of-art Pt/C catalyst with 30 mV more positive potential at -3 mA/cm2 
(Figure 5-1G). On the other hand, the OER behavior of the Mn2O3 showed lower activity as 
compared to the highly active Ir/C and RuO2 catalysts at low current density, but higher activity at 
high current density (Figure 5-1H). 
In order to further understand the origin of the ORR and OER activity, the Cs-MnOx was 
calcined at different temperatures, and the changes in the chemical and electrochemical properties 
were investigated. The material transformed from amorphous (< 450 °C) to crystalline Mn2O3 
(bixbyite) phase (≥ 450 °C) with the heat treatment as evidenced by wide-angle PXRD patterns 
(Figure 2A). No other intermediate phases of Mn and Cs were observed in the PXRD. Cs-MnOx 
materials possessed a Type IV adsorption isotherm regardless of the heat treatment up to 550 °C, 
indicating regular mesoporous structure, while increasing the temperature to 650 °C led to 
destruction of mesoporous structure (Figure 2B). The Brunauer–Emmett–Teller (BET) method 
was used to calculate surface areas of the different Cs-MnOx materials (Table 5-1). Of the different 
Cs-MnOx materials prepared by controlling calcination temperature, Cs-MnOx-350 exhibited the 
maximum surface area (106 m2/g) while Cs-MnOx-450 possessed the largest surface area (86 m
2/g) 
for crystalline Cs-MnOx materials. The Cs-MnOx materials showed monomodal uniform pore size 
distributions upto calcination temperature 550°C (Figure 5-2C). As calculated by the Barrett-
Joyner-Halenda (BJH) method, pore size increased from 3.4 to 7.8 nm with the calcination 
temperature from 250°C to 550°C (Figure 5-2C). The pore size increment can be attributed to the 
interaction of nanoparticles to form bigger size nanoparticles, thus increasing the corresponding 
intraparticle voids.13b Nanoparticle interaction and aggregation can also explain the reduction of 
surface area of catalysts heated at high temperatures. Though mesoporosity of the material was 
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well preserved up to 550 °C, the material calcined at 650 °C exhibited very low surface area (13 
m2/g) with loss of mesoporosity (no Type IV adsorption isotherm, see Figure 5-2B).  
 
Figure 5-2 Structural characterization of Cs-MnOx calcined at different temperatures. (A) 
PXRD patterns, (B) N2 adsorption desorption isotherms, and (C) BJH desorption pore size 
distribution. 
5-4.1. Oxygen Reduction Reaction 
In order to evaluate the electrocatalytic performance of the aforementioned materials, 
catalyst ink was prepared and loaded onto the pyrolytic graphite electrodes (0.28 mg/cm2 mass 
loading for all catalysts). Linear sweep voltammetry (LSV) was tested in 0.1 M KOH solution 
using a rotating disc electrode (see experimental section for detailed experimental conditions). 
LSV polarization curves displayed slight enhancement in ORR activity of the Cs-MnOx upon 
increasing the calcination temperature from 250 oC to 350 oC, however the current was still low 
compared to the Pt/C catalyst (Figure 5-3A, Table 5-1). Upon increasing the calcination 
temperature from 350 oC to 450 oC, a dramatic enhancement in the ORR activity was observed 
with 230 mV positive shift of potential at -3mA/cm2 and significant increase in ORR current. By 
further increasing the calcination temperature above 450 oC, a sharp reduction in ORR activity was 
observed (Figure 5-3A, Table 5-1). The material calcined at 450 °C displayed the highest activity 
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among all calcination temperatures, with superior activity compared to Pt/C and the non-promoted 
manganese oxide calcined at 450 °C (MnOx-450) (Table 5-1). At a current density of -3 mA/cm
2, 
Cs-MnOx-450 showed a potential of -0.14 V vs. SCE (0.87 V vs. RHE), which is 30 mV more 
positive as compared to 20 % wt. Pt/C catalyst and 230 mV more positive as compared to the 
corresponding non-promoted mesoporous manganese oxide (Figure 5-3A). For further 
characterization of the ORR behavior of the most active material Cs-MnOx-450, cyclic 
voltammetry (CV) was tested in both argon and oxygen saturated 0.1 M KOH. The CV curves 
showed no observable ORR behavior in Ar saturated KOH, while a well-defined reduction peak 
was observed in oxygen saturated KOH (Figure 5-3B). Moreover, the highest active Cs-MnOx 
material calcined at 450 °C presented a Tafel slope (69 mV/dec) smaller than that of Pt/C (89 
mV/dec) (Figure 5-3F, and Table 5-1).  
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Figure 5-3. ORR performance of the different catalysts in 0.1 M KOH. (A) LSV polarization 
curves at a scan rate of 5 mV/s and rotation speed of 1600 rpm. (B) CV curves at 25 mV/s for the 
best optimized Cs-MnOx-450 catalyst in both O2 and Ar saturated 0.1 M KOH. (C) LSV curves of 
the Cs-MnOx-450 at different rotation speeds. (B) The corresponding Koutecky–Levich plots for 
Cs-MnOx-450 at different potentials from -0.2 to -0.5 vs. SCE (0.81-0.51 V vs. RHE). (E) i-t 
chronoamperometric responses for Cs-MnOx-450 compared to Pt/C at -0.3 V vs. SCE (0.71 V vs. 
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RHE), with inset showing the effect of methanol addition (blue arrow) on the ORR performance. 
(F) Tafel plots for the ORR of Cs-MnOx-450 (red color) as compared to Pt/C (black color). 
Table 5-1: Summary for the structural parameters and ORR performance for the studied 
catalysts. 
Sample ID Crystal 
structurea 
Surface 
area 
(m2/g)b 
ORR Ej (V) 
@ 
 -3 mA/cm2 c 
Rct (Ω) 
d 
ko (cm s-1) e 
Cs-MnOx-250 Amorphous 79 -0.43 (0.58)  850 0.0004 
Cs-MnOx-350 Amorphous 106 -0.37 (0.64)  550 0.0006 
Cs-MnOx-450 Mn2O3 
(bixbyite) 
86 -0.14 (0.87)  105 0.0032  
Cs-MnOx-550 Mn2O3 
(bixbyite) 
53 -0.43 (0.58)  858 0.0004 
Cs-MnOx-650 Mn2O3 
(bixbyite) 
13 -0.43 (0.58)  1550 0.0002  
MnOx-450 Mn2O3 
(bixbyite) 
150 -0.37 (0.64)  559 0.0006 
20 % wt. Pt/C  N/A N/A -0.17 (0.84)  207 0.0016 
aObtained from PXRD. bDetermined by BET method. cThe potential for ORR measured at a 
current density of -3 mA/cm2 in 0.1 M KOH as extracted from LSV, Potentials are recorded in 
volts versus SCE, and converted to RHE in parentheses. dThe charge transfer resistance (Rct) 
obtained from EIS analysis at a potential of - 0.15 V vs. SCE (0.86 vs. RHE). eThe standard rate 
constant calculated from Rct values (see calculation formulas in the methodology section). N/A 
stands for not applicable. 
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To investigate reaction kinetics, electrochemical impedance spectroscopy was performed, 
and the charge transfer resistance (Rct) was obtained (Table 5-1) from the fitted equivalent circuit 
(using Zimo V3.5 software). The Rct (as determined from the diameter of the semicircle of the 
Nyquist plot at high frequency region) was used to calculate the exchange current density (Jo) and 
the standard rate constant (ko) as two important kinetic parameters for comparing electron transfer 
rates (Rct is inversely proportional to both Jo and k
o, see equations in experimental section). The 
highest active Cs-MnOx-450 showed the smallest Rct (105 Ω) among all studied catalysts, a little 
more than half that of the Pt/C (207 Ω) at a constant potential of -0.15 V vs. SCE (0.86 V vs. RHE). 
Therefore, Cs-MnOx-450 has the highest Jo and k
o among studied catalysts with ~ two fold faster 
electron transfer rate compared to Pt/C (Table 5-1). The Rct values were strongly correlated to the 
activities presented by LSVs in Figure 5-3A. More insights on the ORR kinetics of Cs-MnOx-450 
were evaluated by rotating disc electrode experiments at different rotation speeds (Figure 5-3C). 
The linearity and nearly parallel lines of the Koutecky-Levich plots (Figure 5-3D) indicated a first 
order reaction with respect to the concentration of dissolved oxygen in a four electron transfer 
process.  
The stability of the Cs-MnOx-450 in comparison with Pt/C was tested at a constant 
potential of -0.3 V vs. SCE (0.71 V vs. RHE) using chronoamperometric current-time (i-t) curves 
(Figure 5-3E). The Pt/C catalyst lost 39% of its initial activity after 5.5 h, while Cs-MnOx-450 
displayed much higher stability with a loss of only 15% of its initial activity after 5.5 h and 23% 
after ~ 28 h. Methanol tolerance is a critical feature for the cathode material used in proton 
exchange membrane fuel cells (PEMFCs), specifically in direct-methanol fuel cells.14 Addition of 
methanol to the ORR chronoamperometric experiment of the Pt/C electrocatalyst resulted in a 
complete loss of the ORR activity due to the methanol oxidation by the Pt/C catalyst.15 In contrast, 
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Cs-MnOx-450 exhibited very high methanol tolerance (inset of Figure 5-3E). These results 
signified the robustness of Cs-MnOx-450 as ORR catalyst for direct-methanol fuel cell as well as 
alkaline fuel cells. 
5-4.2. Oxygen Evolution Reaction 
In addition to ORR, we examined the bifunctionality of the Cs-MnOx material by testing the OER 
performance as well. The OER performance of Cs-MnOx was evaluated at different calcination 
temperatures and compared to the highly OER active Ir/C and RuO2 catalysts. Similar to ORR, 
significant variations in OER activity were observed by changing the calcination temperatures of 
the Cs-MnOx. LSV polarization curves displayed slight enhancement in OER activity when the 
calcination temperature increased from 250 oC to 350 oC followed by a dramatic enhancement in 
activity when the calcination temperature increased from 350 oC to 450 oC as shown by the 
enhancement in current and the shift of onset potential to a less positive potential. Significant 
decrease in the activity was then noted when the calcination temperature increased to 550 oC and 
650 oC (Figure 5-4A, Table 5-2). The charge transfer resistance obtained from the fitted data 
circuit of the EIS spectra at 0.7 V vs SCE. (1.71 V vs. RHE) confirmed the same trend seen in 
LSVs. The smallest Rct of all calcination temperatures of Cs-MnOx was recorded for Cs-MnOx-
450 (50 Ω), which is close to that of the highly active Ir/C (37 Ω) as shown in Figure 5-4C. The 
small Rct value of the Cs-MnOx-450 reflected a high electron transfer rate as shown by the values 
of exchange current density and standard rate constant (Tables 5-2). At 10 mA/cm2, LSV of the 
best optimized Cs-MnOx catalyst (Cs-MnOx-450) showed 50 and 60 mV more positive potential 
compared to Ir/C and RuO2 catalysts respectively. However, at a high current density (> 26 
mA/cm2), Cs-MnOx-450 outperformed both Ir/C and RuO2 with less positive potential observed 
for Cs-MnOx-450 (Figure 5-4A). 
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Figure 5-4. Electrochemical characterization of OER in 0.1 M KOH. (A) LSV of different 
catalysts at a scan rate of 5 mV/s. (B) CVs of the highly active Cs-MnOx-450 compared to Ir/C, 
and RuO2 at scan rate of 5 mV/s. (C) EIS at potential of 0.7 V vs. SCE (1.71 V vs. RHE) and a 
frequency range of 0.1 to 105 Hz. (D) Chronopotentiometric curves (not iR compensated) at 10 
mA/cm2 showing superior stability of Cs-MnOx-450 compared to Ir/C and RuO2. 
OER performance of Cs-MnOx-450 was tested at extreme working potentials to study the 
change in the catalytic efficiency at extreme conditions. A nearly linear LSV curve was observed 
for potentials up to 1.7 V vs. SCE (2.71 V vs. RHE) achieving a very high current of 400 mA/cm2, 
suggesting the capability of Cs-MnOx-450 to work at low and high working potentials with 
reasonable efficiency. Tafel slopes of Cs-MnOx-450 and Ir/C were also compared at low and high 
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potential regions. In the low potential region, Cs-MnOx-450 showed a Tafel slope of 100 mV/dec 
that is higher than that of Ir/C (80 mV/dec). However, Cs-MnOx-450 displayed a smaller Tafel 
slope at high potentials as compared to Ir/C suggesting faster oxygen evolution reaction rate for 
the Cs-MnOx-450 at high potentials. Moreover, CV curves of the Cs-MnOx showed well-defined 
and sharp CV curves with both anodic and cathodic curves nearly superimposed on one another 
(Figure 5-4B). The stability was tested using chronopotentiometry at 10 mA/cm2 with a maximum 
potential limit of 0.9 V vs. SCE (1.91 V vs. RHE) (Figure 5-4D). The Cs-MnOx-450 spent 15 h 
before the potential was shifted to 0.9 V vs. SCE which is almost four times higher stability 
compared to Ir/C and RuO2. Moreover, Cs-MnOx-450 showed much higher activity and stability 
compared to other forms of manganese oxides we have recently reported.9b The superior activity 
of the Cs-MnOx-450over Ir/C, RuO2, and commercial Mn2O3 along with the high stability suggest 
that Cs ion promoted mesoporous manganese oxide is a strong candidate for water electrolyzers 
as well as fuel cells. 
To gain full assessment about the properties of the catalyst in the oxygen evolution reaction, we 
determined Faradaic efficiency of Cs-MnOx catalysts using a completely sealed H-shaped 
electrochemical cell in a three electrode configuration. The Pt counter electrode was positioned in 
the left arm of the cell, while the Ag/AgCl reference, working electrode, and the oxygen sensor 
were placed on the right arm. The cell was filled with 0.1 M KOH as electrolyte and purged for 30 
min with purified nitrogen before running the experiment.    
An amperometric (current-time) experiment was performed with an input potential of 0.8 V vs. 
SCE for 3 min reaching a current of 106 mA. The theoretical number of moles of oxygen evolved 
can be calculated from Faraday’s 2nd law of electrolysis according to the following equation: 
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n𝑂2(theortical) =  
Q
nF
=
i x t
nF
=
0.106 (A)x 180 (s)
4  x 96485.3 s A mol−1
= 49.4 x 10 −6mole                 (1) 
where nO2 is the number of moles of oxygen produced, Q is the total charge passed during 
electrolysis, n is the number of electrons transferred during OER (4 e), i is the applied current in 
amps, t is the electrolysis time in sec, and F is the Faraday constant 96485.3 s A mol-1. 
The oxygen sensor detected the total number of moles of oxygen produced to be 45.2 x 10-6 moles. 
The faradic efficiency is = 
n𝑂2(experimental)
n𝑂2(theortical)
 𝑥100 = 91.4 %                                    (2) 
These results verify that the current of the working electrode is exclusively caused by the oxygen 
evolution reaction. 
Table 5-2: Summary for the OER electrocatalytic performance for the studied catalysts 
Sample ID Ej (V) @  
10 mA/cm2 a 
Rct  (Ω) 
b
ko (cm s-1) c E (OER-ORR) 
(V) d 
Cs-MnOx-250 0.90 (1.91) 412 0.0008 1.33 
Cs-MnOx-350 0.86 (1.87) 256 0.0013 1.35 
Cs-MnOx-450 0.64 (1.65) 50 0.0067 0.78  
Cs-MnOx-550 0.90 (1.91) 360 0.0009 1.33 
Cs-MnOx-650 > 1.09 (2.10) 1450 0.0002 > 1.42 
MnOx-450 0.71 (1.72) 137 0.0025 1.08 
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20 % wt. Pt/C  1.0 (2 .01) N/A N/A 1.17 
20 % wt. Ir/C  0.58 (1.59) 37 0.0091 0.96 
RuO2 0.59 (1.6) N/A N/A N/A 
All data in the tables are extracted from the LSV and EIS experiments in 0.1 M KOH at a 
rotation speed of 1600 rpm. a Potentials measured from LSV at a current density of 10 mA/cm2, 
potentials are recorded in volts versus SCE, and converted to RHE in parentheses. bThe charge 
transfer resistance (Rct) obtained from EIS analysis at 0.7 V vs SCE. (1.71 V vs. RHE). 
c The 
standard rate constant as calculated from Rct values. 
dThe potential difference between OER at 10 
mA/cm2 and ORR at -3 mA/cm2.  
5-4.3. XANES and EXAFS Analysis 
To study the role of the Mn oxidation state for enhancing ORR and OER activity, X-ray 
absorption near edge structure (XANES) was used for the precise monitoring of the change in the 
average Mn oxidation state of the Cs-MnOx calcined at different temperatures. Figure 5-5A shows 
the Ex-situ XANES spectra of Cs-MnOx calcined at 250 °C to 550 °C. Figure 5-5A showed shift 
of the XANES spectra to higher energy upon increasing calcination temperature from 250 °C to 
400 °C indicating an increase in the average Mn oxidation state, followed by a shift to lower energy 
when the calcination temperature further increased to 450 °C or 550 °C indicating a subsequent 
decrease in Mn oxidation state. Different manganese oxides with variable oxidation states of Mn 
(MnO, Mn3O4, Mn2O3, MnO2) were used as standards for the linear combination fitting (LCF) of 
the XANES spectra of the Cs-MnOx calcined at different temperatures to monitor the contribution 
of the different manganese oxide phases and track the change of the oxidation state as well upon 
calcination (Figure 5-5B). Figure 5-5B showed the LCF results of the XANES spectra revealing 
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the contribution of each Mn oxidation state at each calcination temperature. LCF results showed 
that all samples calcined to a temperature below 450 °C have mixed Mn valence, while 
transformation to pure bixbyite phase occur at 450 °C and 550°C. Figure 5-5C shows the change 
of the average Mn oxidation state from 2.97 to 3.34 when the calcination temperature increases 
from 250 °C to 400 °C, then the Mn oxidation state dropped back to 3.00 when the calcination 
temperature increases to 450 °C or 550 °C (Figure 5-5C). The trend observed in the XANES 
analysis upon conversion from 350 °C to 550 °C was confirmed by the EXAFS analysis (Figure 
5-5D). Furthermore, the effect of applying constant potentials for ORR (-0.3 V vs. SCE for 5 h) 
and OER (0.7 V vs. SCE for 1 h) on the oxidation state of Mn in the best optimized Cs-MnOx-450 
was investigated using XANES analysis (Figure 5-6). Results showed that exposing Cs-MnOx-
450 to either ORR or OER induced changes in the valence of Mn centers of the catalyst. After 
exposing Cs-MnOx-450 to ORR for 5 hours, the average oxidation state of Mn shows no 
significant change (from 3.00 to 3.02). However, the contribution of the different Mn oxidation 
states to the average oxidation state showed significant changes with dropping of the percentage 
of Mn3+ from 100 % to 71 %, as well as increasing the percentage of Mn4+ from 0.0 to 9.0 %. In 
case of exposing Cs-MnOx-450 to OER for 1 h, the average oxidation state increased from 3.00 
to 3.17 where percentage of Mn4+ increased from 0 to 23 % along with decrease in the percentage 
of Mn3+ to 57 % (Figure 5-6).  
5-5. DISCUSSION  
The structures and surface area of metal oxides are believed to be main decisive factors in 
the ORR and OER catalysis as structural flexibility and surface accessibility are important degrees 
of freedom. For the rational design of highly active ORR and OER metal oxide catalysts, it is often 
difficult to choose crystalline phase or amorphous phase as the active form of catalyst.7a, 16 In our 
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study, we were able to tune high surface area mesoporous manganese oxide from amorphous phase 
to crystalline one by mere heat treatment for developing exceptionally active manganese oxide 
catalysts. Our materials, unlike conventional mesoporous materials, have a connection of 
intraparticle voids of closely packed manganese oxide nanocrystals that form the mesoporous 
structure.13 Amorphous Cs-MnOx materials calcined at 250 °C and 350 °C showed much lower 
catalytic activity (in terms of current and onset potential) for ORR and OER than crystalline Cs-
MnOx calcined at 450 °C (bixbyite phase). Interestingly, the surface area of the amorphous Cs-
MnOx-350 (106 m2/g) is 23 % higher than crystalline Cs-MnOx-450 (86 m2/g), yet the activity of 
Cs-MnOx-450 for ORR and OER is much higher, indicating that the effect of crystallinity is 
masking the effect of surface area. The Cs-MnOx calcined at 550 °C also possessed the bixbyite 
(Mn2O3) phase with 38 % lower surface area than Cs-MnOx-450 explaining the drop in the ORR 
and OER activity upon increasing the calcination temperature from 450 °C to 550 °C. On the other 
hand, the much lower surface area of both Cs-MnOx-650 (13 m2/g) and commercial Mn2O3 (12 
m2/g), explains the relatively inert behavior under electrochemical conditions. Furthermore, we 
verified the performance of Cs-MnOx-450 and commercial Mn2O3 in OER by normalizing the 
current to the true surface area. Figure S9 revealed that the Cs-MnOx-450 showed higher current 
density than commercial Mn2O3 even after normalizing the surface area.  These results suggest 
that the combination of high surface area and crystalline structure are determining factors behind 
the superior performance of Cs-MnOx-450 as an electrocatalyst. In order to confirm the influence 
of specific surface area on the electrochemical behavior, we investigated the electrochemically 
active surface area (ECSA) of Cs-MnOx at different calcination temperatures (determined from 
the capacitance). Cs-MnOx-250 showed a capacitance of 22 mF/cm2 that almost doubled when the 
calcination temperature increased to 350 oC (41 mF/cm2) indicating an increase in the accessible 
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electrochemical active surface area to the electrolyte. The capacitance was then dropped to 20 
mF/cm2 when the calcination temperature increased to 450 oC, followed by further decrease in the 
capacitance at 550 oC (13 mF/cm2). The change of the ECSA is in great agreement with findings 
from BET. However, ECSA has much lower values than the surface area determined by BET (See 
SI for more details) because of the limited access of the electrolyte to the pores of the catalyst 
compared with the inert gas used for BET.   
 
Figure 5-5. Ex-situ XANES and EXAFS study for Cs-MnOx catalysts. (A) Normalized Mn K 
edge XANES spectra. (B) Linear combinations fits of data in A. (C) Corresponding change of Mn 
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oxidation state obtained from XANES analysis via linear combination fitting. (D) Ex-situ EXAFS 
of Cs-MnOx samples calcined at 350 oC - 550 oC showing change in EXAFS spectra upon 
conversion from amorphous (350 oC) to bixbyite phase (450 oC and 550 oC). 
Oxidation state of active manganese centers is critical for designing active ORR and OER 
manganese oxide catalysts. The success of catalytic activity in ORR and OER largely depends on 
the role of the Mn3+ oxidation state as the intermediate species for these reactions.17 Several 
strategies have been adopted to generate the active Mn3+ species irrespective of the initial oxidation 
state of Mn to enhance the catalytic activity.11b, 18 The high catalytic activity of the Mn3+ species 
is attributed to the presence of one electron in the antibonding eg orbital (eg
1) which result in Jahn-
Teller (J-T) distorted metal-oxygen octahedra. Moreover, the presence of single electron in the eg
1 
results in the appropriate interaction between O2 and the manganese oxide catalyst required for 
efficient ORR and OER.19 Linear combination fitting of the XANES spectra revealed the 
contribution of Mn3+ to the catalytic ORR and OER activity. However, though the average 
oxidation state of Mn in Cs-MnOx-250 is ~3.00 (exactly 2.97), the ORR and OER activities are 
relatively low as the result of the mixed Mn valence with only 25 % of Mn ions in the form of 
Mn3+ (Figure 5-5). Slight enhancement in ORR and OER activity was observed as the percentage 
of Mn3+ increases when the calcination temperature increases to 350 °C. The highest ORR and 
OER activity among all calcination temperatures was achieved only when the contribution of Mn3+ 
reached 100 % in case of Cs-MnOx-450. XANES analysis was further used to monitor the effect 
of exposing Cs-MnOx-450 to ORR and OER reactions to explain the slight decrease in stability 
overtime (Figure 5-6). LCF of XANES results revealed that exposure to ORR and OER induced 
a change in the contribution of different Mn oxidation state with dropping in the percentage of 
Mn3+ (Figure 5-6). These results suggest that an average Mn oxidation state of 3 alone does not 
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produce active ORR and OER manganese oxide catalyst, but rather higher percentage of Mn3+ in 
the form of bixbyite phase is the main reason behind superior ORR and OER activity in manganese 
oxide. 
 
Figure 5-6. Normalized Mn K edge XANES spectra for the as prepared Cs-MnOx-450, after 
exposure to ORR for 5 h at -0.3 V vs. SCE, and after exposure to OER for 1 h at 0.7 V vs. SCE. 
The average Mn oxidation state changed from 3.00 to 3.02 in case of ORR, and to 3.17 in case of 
OER. 
The role of Cs in altering the bulk and surface properties of Cs-MnOx material compared 
to nonpromoted MnOx material was investigated to understand the origin of the high ORR and 
OER activity of the Cs-MnOx material. Temperature resolved powder X-ray diffraction (TR-
PXRD) was performed on Cs-MnOx and MnOx (calcined at 250 °C) to investigate the phase 
transformation with heat treatment (Figures 5-7 and 5-8).  
 
119 
 
 
Figure 5-7. The temperature resolved powder X-ray diffraction (TR-XRD) MnOx material under 
air.The material was calcined at 150 °C for 12 h and 250 °C for 3 h prior to measurement. 
 
Both of the materials are amorphous at room temperature. A clear difference can be seen 
in the crystallinity of the materials with and without the introduction of Cs ions. In the 
nonpromoted sample, the amorphous state crystallizes first to the vernadite (MnOOH) phase 
before undergoing rearrangement to the bixbyite (Mn2O3) phase (Figure 5-7). The addition of Cs
 
ions resulted in the destabilization of vernadite phase and presenting bixbyite phase with no 
intermediary phase (Figure 5-8). 
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Figure 5-8. The temperature resolved powder X-ray diffraction (TR-XRD) Cs-MnOx material 
under air. The material was calcined at 150°C for 12 h and 250°C for 3 h prior to measurement. 
 
 The amorphous state of the material was stable > 350 °C for Cs-MnOx (crystallized at 
400°C), whereas, MnOx crystallized at 350°C. Thermalogravimetric analysis (TGA) (Figure 5-9) 
supports the destabilizing effect due to Cs introduction by showing a full 15 % increase in mass 
loss which was ascribed to labile oxygen in the amorphous phase compared with MnOx, which 
exhibited a higher thermal stability and by extension, less labile oxygen.  
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Figure 5-9. The thermogravimetric analysis of Cs-MnOx and MnOx materials under air. Both of the 
materials were calcined at 150 °C for 12 h and 250 °C for 3 h prior to measurement. 
 
The nonpromoted MnOx displayed the presence of both active Mn3+ along with less active 
Mn4+ species (80/20 ratio) as determined by the deconvoluted Mn2p3/2 XPS spectra (Figure 5-10). 
The presence of Cs stabilized the active Mn3+ species with no other Mn oxidation states. These 
results indicate that the presence of surface active Mn3+ species and stabilization of active crystal 
phase (Mn2O3) are the main reasons of the superior ORR and OER activity of Cs-MnOx over 
MnOx. The strong adsorption of protons (due to the OH- dissociation) is one of the important 
factors for a facile OER catalyst in alkaline medium.9b The remarkable activity of the Cs promoted 
material over the non-promoted material can be also be ascribed to the increase of relative basicity 
of the materials.  
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Figure 5-10. The  XPS analysis of  Mn 2p spectra of (A) MnOx-450 and (B) Cs-MnOx-450 materials. 
The MnOx material shows the presence of Mn3+ along with Mn4+ valency (Mn3+/Mn4+), whereas Cs-MnOx 
shows the presence of only Mn3+ species. 
The CO2 chemisorption measurements revealed the more basic nature of Cs-MnOx over 
MnOx at three different probe temperatures (Figure 5-11). The acidic CO2 adsorbed more into the 
basic material, which is in line with our previous work, where the basic nature of Cs-MnOx was 
the reason for superior chemical oxidation and esterification catalysis.27 
 
Figure 5-11. The CO2 adsorption of Cs-MnOx and MnOx materials calcined at 250 °C for 3 h at 
(A) RT, (B) 0 °C and, (C) -78 °C. 
 
A B
123 
 
To further study the role of surface and bulk manganese centers in relation to activity, ab-
initio models for three bulk oxides of manganese (MnO, Mn2O3 and MnO2) were optimized using 
density functional theory (DFT), and their experimentally relevant surface terminations, [200], 
[222] and [110], respectively, were generated to model the thermodynamics of ORR and OER 
reaction as two reversible processes (Figure 5-12). The overall reaction of ORR in a four electron 
transfer process is shown in Eqn. 3: 
O2 + 2H2O + 4e
-                       4OH-                                 (3) 
The ORR mechanism catalyzed by manganese oxide can be expressed as:10c, 20  
MnOx + H2O + e
-                     MnOxOH + OH
-                (4) 
MnOxOH + 
1/2 O2                    MnOxOH----O                   (5) 
MnOxOH----O + e
-                    MnOx + OH
-                                (6) 
 
Table 5-3: Bader charge analysis of MnOx in the bulk and surfaces 
Location MnO Mn2O3 MnO2 
Surface 1.32 1.61 1.71 
Bulk 1.42 1.73 1.83 
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Figure 5-12. (A) Bulk structure of MnO, Mn2O3 and MnO2 with their relevant experimental 
surface terminations. Purple atoms are Mn and red atoms are O. (B) Elementary reaction pathway 
for the dissociation of H2O on MnOx terminated surfaces. 
The thermodynamic reaction pathway for the dissociation of water was meticulously 
analyzed (Figure 5-12B, 5-13). The overall reaction pathway illustrated that MnO2 surfaces have 
the lowest ∆H between consecutive steps, and often the lower the ∆H between consecutive steps 
the lower its associated Ea, based on the guidelines of Sabatier’s principle. Given these three 
surface terminations, the thermodynamic preference is: MnO2 > Mn2O3 > MnO suggesting that 
MnO2 surfaces would require the least reduction potential. 
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Figure 5-13. Model of H* and OH* adsorbate species on Mn2O3 surface 
 
However, terminating a surface reduces its coordination.21 To identify the active oxidation 
states on the Mn surfaces, a Bader charge analysis22 was conducted on Mn ions in their 
corresponding bulk phase and on the surface. Table 3 summarizes the observed charges at the two 
locations. Mn ions on the MnO2 surface have an identical charge to Mn ions in bulk Mn2O3 which 
are known to be in the +3 oxidation state.  This observation along with the favored thermodynamic 
activity behavior on the MnO2 surface suggests that Mn3+ ions are contributing positively to an 
enhanced ORR/OER activity. Moreover, the change in the charge between the surface and bulk of 
the same oxide suggested the necessity of tuning the surface of metal oxides to achieve the active 
oxidation state for ORR and OER as presented in our current study as the role of Cs. 
5-6. SUMMARY 
In summary, we have successfully tuned mesoporous manganese oxide from amorphous 
to crystalline phase along with exploring the role of surface and bulk active manganese centers to 
achieve exceptional ORR and OER activities. The crystalline phase of our mesoporous manganese 
oxide material outperformed the amorphous phase for both ORR and OER. Findings from 
XANES, EXAFS, XPS, PXRD, and DFT calculations revealed the critical role of the surface and 
H* OH*
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bulk active Mn3+ for enhancing the catalytic activity for ORR and OER. By incorporating a minute 
amount of electropositive Cs ions (0.16 %), surface enriched Mn3+ was achieved, and the catalytic 
activity in both ORR and OER was significantly enhanced compared to pure mesoporous 
manganese oxide (5 times faster reaction rate in ORR and 7 orders higher turnover frequency in 
OER). Moreover, the best optimized Cs-MnOx-450 material exhibited better bifunctional oxygen 
reaction activity than precious metal catalysts: Pt (in ORR) and Ir, Ru (in OER at high current 
density) and other noble metal free manganese based catalysts reported to date. Precise control 
over the structural and surface properties by simple heat treatment made Cs-MnOx a ubiquitous 
electrocatalyst and opens up new avenues in the field of alternate energy applications in terms of 
non-expensive and earth-abundant metal oxides.  
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CHAPTER 6 
Flexible, Stretchable, and Self-powered Sensor Enabled by Ferrofluid 
Triboelectrification for Mechanical and Biomedical Applications 
6-1. ABSTRACT 
The fabrication of efficient and multifunctional sensing/harvesting systems for mechanical, 
magnetic and acoustic energy is great significance for wearable and biomedical applications. 
Herein, we present a novel ferrofluid-solid interface based triboelectric nanogenerator (ferro-
TENG) featuring diverse multi-functionality. The magnetized nanoparticles of the ferrofluid play 
a crucial role in achieving an efficient charge exchange with the tribo layer (silicone) leading to 
an enhanced triboelectrification and device performance. The unique properties of the ferrofluid 
constituent of the device allowed the fabrication of TENG devices that are flexible, stretchable, 
and have the ability to sense and harvest magnetic, mechanical and acoustic energies. The 
waterproof properties of the ferrofluid-TENG made it excellent candidate for under water 
wearables and soft robotics applications which are capable of harvesting and sensing the water 
wave energy. Wearable pressure Ferro-TENG sensor enabled monitoring biceps and triceps 
resistance bands, a promising approach for flexural and stretching pressure sensing. Additionally, 
it was used for sensing and harvesting acoustic energies at different sound frequencies which make 
it a good candidate for hearing aids. Scavenging and quantification of magnetic field energies was 
a novel approach that was used to detect the magnetic field intensity and rotation velocity of 
magnetic rotatory motors. The ability of the sensor to produce measurable electrical signal without 
the need to external power source would be of interest specially in biomedical health monitoring, 
robotics and artificial skin applications.      
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6-2. INTRODUCTION 
Triboelectric nanogenerators (TENGs) are promising devices for harvesting mechanical 
energy due to their high efficiency, low cost, lightweight and easy fabrication. TENGs couple 
triboelectrification and electrostatic inducement to produce electrical signals from mechanical 
energy 1. Their high power outputs have been applied in chemical 2, magnetic 3, hydrokinetic 4, 
thermal 5 and acoustics 6 energy harvesting networks. Furthermore, their design showed less 
harmful impacts with significant environmental compatibility allowing their utilization in efficient  
energy harvesting designs 7. The nanogenerators would use multiple energy modes coupled with 
other generators as piezoelectric 8, pyroelectric 9 and electromagnetic 10 generators for improving 
energy harnessing that can be potentially used in a wide range of applications as energy harvesters 
with surroundings-tailored energy scavenging.  
Recently, a design containing electromagnetic generators (EMG) used for mechanical 
energy harvesting has been established 11. A more recent design composed of TENGs and EMGs 
couples was proposed by adding a ferrofluid content with magnetized nanoparticles controlled by 
the applied magnetic fields that could be employed to determine solid-solid abrasions, scrubbing 
and collision degradation 12. Ferrofluids have been utilized in magnetic resonance imaging (MRI) 
as contarst agent 13 and thermal mangement of electronics 14. The liquid nature of the ferrofluid 
resists physical stresses encountered by triboelectric modes. When a magnetic field triggers the 
integrated magnetized nanoparticles in the ferrofluid, the fluidic nature is maintained as a robust 
and durable system.  
Stretchable energy harvesters have been manufactured 15 and examined to solve strain and 
portability issues for biomedical 16, sensing and micro-actuation applications17. Self-powered 
systems offer a compact, durable and portable approach to overcome limitations associated with 
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energy supply requirements. In this context, we introduce a hybrid stretchable TENG device based 
on liquid-solid interface, containing ferrofluid material with magnetized nanoparticles which have 
the advantage of potential field operations and sensing functionality. This ferro-TENG device was 
extended to include remote sensory work in biceps and triceps resistance which allows the 
monitoring of the applied forces. In addition, it was utilized to sense and harvest the magnetic field 
created by the rotary magnetic tools with the ability to measure the magnetic strength and rotation 
speeds generated from such rotary devices. Interestingly, the presented design was applied to 
detect a magnetic field via the included ferrofluid constituents for wearable electronic-skin device 
underwater and involved in a flexible robotics. The fabricated construct was able to detect wave 
speed and acoustics origin at various pressure levels. This approach would allow visualization of 
magnetic fields as provisional hardware for dependent mechanical expansion and physiological 
assessment. 
6-3. EXPERIMENTAL SECTION 
6-3.1. Materials:  
Ferrofluid was purchased from Ferrotec (USA) Corporation; the mixture composition 
consists of magnetite (5% v/v), oil soluble dispersant (30%) and carrier liquid (55%). 
6-3.2. Methods:  
Ferro particles preparation for the concentration test:  
The ferro particles were separated from the ferro fluid through putting it on the hot plate 
for few seconds at 400 °C. Then added these particles with specific amount on the ferrofluid and 
mixed well. Then, it left for 24 hours for completely dissolve inside the ferrofluid on the sonicator. 
Electrical Measurements:  
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The generated current and voltage were obtained and recorded by a voltage preamplifier 
(Keithley 6514 System Electrometer) using customize LabVIEW interface.   
Pressure sensor measurement setup: 
The ferro-TENG was mounted vertically on a 3D positioner. Then, align the contact object 
with a force sensor and vertically mounted the force sensor along with the contact object to one 
end of the linear motor for reciprocating motion. And then, the ferro-TENG output was monitored 
by using an electrometer and the interaction force between ferro-TENG and the object. Finally, 
the stroke distance of the linear motor was changed by changing the interaction force to investigate 
the dependence of voltage on the contact pressure. 
6-4. RESULTS & DISCUSSION  
(a) 
 
(b) 
 
Figure 6-1. (a) Potential applications of ferro-TENG as a wearable pressure, acoustics and 
magnetic sensors. (b) Scheme of the ferro-TENG applied as wearable magnetic and biomechanical 
sensors on different human body parts. 
      Powering a TENG with ferrofluid offer an opportunity to capture, quantify and analyze 
magnetic waves at very low magnetic flux in addition to improving the device sensitivity towards 
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pressure tension and acoustic energy.  Ferro-TENG would offer a flexible and stretchable sensitive 
self powered approach that can be utilized in wearable pressure sensors and magnetic sensing 
applications as demonstrated in Figure 6-1a. The ferro-TENG would be also for acoustic energy 
sensing which is useful for the detection of sound waves in microphones, hearing aids, and portable 
electronics.Potential applications of the ferro-TENG in wearable magnetic sensor and wearable 
biomechanical sensor was illustrated in Figure 6-1b. The proposed multifunctional energy 
sensing/harvesting ferro-TENG design allowed attaching the ferro-TENG on clothes for tracking 
applications. The device durability, elasticity and Stretchability made it possible to attach this 
ferro-TENG to different dynamic body parts like knee, shoulder, or directly to the skin for the next 
generation of wearables and bio-tactile sensors such as cloth communication devices, electronic 
textiles, and robotic sensory skin. 
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
 
(f) 
 
Figure 6-2. Fabrication and characterization of elastomeric microtubes with ferrofluid. (a) 
Scheme of the self-charged microtube device with a ferrofluid-triboelectricities and schematic 
flow diagram for the fabrication procedures stating with filling silicone rubber tube with ferrofluid 
followed by integration of coiled copper inside Efcoflex® gel housing. (b) Photographs of the 
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ferro-TENG device showing its flexible deformation into various shapes and elastic expansion to 
more than 300% of its original size. Structure optimisation and ferro-fluid effect on the ferro-
TENG. (c) The effect of the internal tube diameter on the performance of ferro-TENG in harvesting 
mechanical energy. (d) The effect of varying concentration of ferrofluid ferro nanoparticles on 
ferro-TENG response to applied magnetic field. (e) The effect of different ferrofluid fill ratios 
inside the silicone tube on ferro-TENG behaviour in applied magnetic field. (f) The ratio between 
ferro-TENG open circuit productivity and ferrofluid fill ratio, maximum sensitivity was obtained 
with 60% fill ratio. 
     Design and fabrication of the proposed ferro-TENG device was illustrated in Figure 2. The 
proposed ferro-TENG composed of a middle silicone shell filled with the ferrofluid and 
surrounded by a coiled copper wire integrated into outer Ecoflex® gel layer. Ferrofluid was first 
injected into silicone tube to the required fill ration then tube was then sealed on both ends. Copper 
wire was coiled in a thread-like shape on the outer surface of the silicone tube and then covered 
by Ecoflex® gel which was then cured at 100˚C (Figure 6-2a). The threaded-shape copper wire 
supported the stretchability of as fabricated ferro-TENG device. The flexibility and stretchability 
of the ferro-TENG device were examined in different conditions including bending, twisting and 
crumping. Moreover, it had been tested at different strains (Figure 6-2b). The introduced device 
achieved excellent stretchability expanding ~ 300% of it’s original size before breakage proving 
high elasticity of the proposed ferro-TENG. To optimize the performance of the proposed ferro-
TENG design several parameters have been tested. The effect of internal silicone tube diameters 
on the capability of ferro-TENG in harvesting mechanical motion was tested (Figure 6-2c). 
Increasing the internal silicone tube diameter from 1.5 mm to 6.0 mm improved the device 
response almost 400% this is mainly due to the increase in the contact area between ferrofluid and 
sisicone tube surface. Although wider diameter may improve the device performance, the device 
applicability would be compromised with bigger sizes. The effect of varying ferro nanoparticles 
concentrations on the open circuit voltage (VOC) output was studied and presented in Figure 2d. 
The \ferro nanoparticles concentration was found to be correlated to VOC when the concentration 
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increases from 5% to 15% before reaching the steady state in concentrations of 20% or higher 
(Figure 6-2d). The effect of the fill ratio of the ferrofluid inside the silicone tube on the response 
of ferro-TENG to applied magnetic field was also studied. Open circuit voltage increased with 
increasing fill ratio from 10 - 60%, then diminished. So, the maximum corresponding output was 
approximately 60% (Figures 6-2e, f). This behaviour can be attributed to increased dynamic flow 
friction between ferrofluid and tube surface with increasing fill ratio until it reached its maximum 
at 60% after which flow of ferrofluid inside the tube would be limited decreasing the output 
performance.     
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Figure 6-3. Operating principle of the multifunctional ferro-TENG nanogenerator: Taping 
mode (a) Operating principle of the ferro-TENG in taping mode. (b) Finite element simulation of 
the distribution in the TENG with varying gap distances between contact layer and silicone tube. 
Tapping mode Electrical signal output (c) Open-circuit voltage signals, (d) Current signals (e) 
Instantaneous power (microwatt) and peak voltage versus the loading resistance. Magnetic mode. 
(f) Operating principle of the ferro-TENG powered by magnetic responsive ferrofluid. (g) Open-
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circuit voltage signals (h) Current signals (i) Instantaneous power (microwatt) and voltage peak 
versus the loading resistance.  
     Operating principle of the proposed ferro-TENG is based on the induction of electrical signal 
as a response to external stimuli. With the aid of the magnetic responsive ferrofluid, external 
stimuli can be pressure, acoustic energy or magnetic field. Figure 6-3a demonstrates the pressure 
responsive (Tapping mode) single electrode ferro-TENG platform in which the latex layer was 
used to represent an external stimulus activating the silicone tube that act as Tribo-layer. In absence 
of physical contact between the latex and silicone layers, no charge transfer occurs leading to no 
electrical potential build up. When a contact between the latex and silicone tube takes place, 
charges are produced and transported from their corresponding surfaces which generate negative 
and positive charges equivalently at their contact interfaces. When ferro-TENG is separated form 
rubber layer, the electrons move from the ground electrode to the copper wire as the result of the 
potential difference (Figure 6-3a). When the distance between the two contact surfaces increases, 
the current flow stops as it reaches the electrostatic equilibrium. Simulation studies showed electric 
potential distribution and the charge transfer as function of the distance between the latex and the 
silicone tube in the ferro-TENG device. When the silicone tube was connected to the latex layer, 
the electric potentials on both layers approached zero, and the triboelectric charge density was 
measured to be 50 μCm−2. The electric potential difference was found to increase significantly 
with increasing separation distance. At the gap distance of 5 mm, the potential difference 
approached 12 V, confirming increase of output voltage upon increasing the separation distance 
(Figure 6-3b).  
The ferro-TENGs electrical energy outputs were determined by different cycles of 
pressings the latex on the silicone tube. The measured potential (Voc) and current (Isc) after directly 
pressing and releasing silicone tube layer at different cycles showed that the maximum voltage 
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was 12 V and maximum current was 25 nA  (Figures 6-3 c, d). The electrical energy output was 
assessed as the peak voltage values when different resistances were applied. The power (P) is 
obtained from the formula (P=V2/R), where (R) denotes the electrical resistance and (V) denotes 
the voltage. It can be observed that the estimated voltage is close to zero in the short circuit 
condition (almost no resistance). As the resistance increases, the voltage relatively grows and 
reaches the maximum value (~ 12 V) in the open circuit condition (very high resistance). As the 
resistance increases to 50 MΩ, the output power reached the peak value of 60 µW (Figure 6-3e).  
As the latex approach the silicone tube again, the electrons flow from the copper wire 
electrode to the ground until the latex and silicone tube are in full contact with each other, resulting 
in a reversed output charge transfer (Figure 6-3e). Same process explained above can be seen in 
Figure 6-3f-i, however, in this case the magnetic field is the driving force. In this case the contact 
will happen between the ferrofluid and the silicone tube when the magnet keeps approaching the 
ferro-TENG device. The electrical energy outputs of the ferro-TENGs were assessed through 
different cycles of applying magnetic field. The measured Voc and Isc at different cycles from 
applying and removing magnetic field indicated that the maximum voltage was 6 V and the 
maximum current was 4 nA (Figures 6-3 g, h). As the resistance increases, the output power 
reached the peak value of 3.5 µW when the resistance equals to 50 MΩ (Figure 6-3i).  
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Figure 6-4. Self-powered wearable biomechanical sensor showing the flexibility of the ferro-
TENG (a) Signal at different stretching strains showing the increasing TENG output with higher 
stretching extents. (b) electrical signal from Crumpling. (c) Electrical signal from Twisting. (d) 
Knee-ready ferro-TENG biomechanical tracking sensor. (I) Ferro-TENG device positioned on the 
knee, (II) Changes in the ferro-TENG electrical signal output with various motion types including: 
walking, running, jumping, and marching. (e) The relationship (blue) and linear fitting (red) 
between relative measured current (ΔI/I0) against the applied pressure up to 80 KPa showing 
varying sensitivities(f) voltage profiles from pressure sensor as a function of time at different 
pressures applied to the device. (g) Stability study showing change in output current with repeated 
loading and unloading pressure cycles of 80 kPa.  
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Fabricated ferro-TENG showed increase in the open circuit output signals with increasing 
stretching levels that reached 300% of the device original size (Figure 6-4a). The sensor was found 
to perform perfectly after relaxation with no notable change in performance after several stretching 
cycles. In addition, crumpling/uncrumpling and twisting/untwisting movement cycles were 
monitored in life time (Figure 6-4b and 6-4c). The sensor signals (accelerometer) for different 
motions such as walking, running, jumping, and marching was monitored using ferro-TENG as 
shown in Figure 4d with Signal intensity proportional to the motion intensity (Figure 6-4d).  
The ferro-TENG device was also responsive to change in the applied pressure as high 
pressure applied to contact area would result in high charges density at the contacting surfaces 
increasing electron transfer and consequently increase in the generated current at the interface. 
Three distinct pressure to current correlation regions were observed, the first was the low-pressure 
region (< 25 KPa), at which the pressure sensitivity was 0.07 KPa-1 with an excellent regression 
(R2 = 0.98). The second region was between 25 KPa to 40 KPa where the pressure sensitivity 
dropped to 0.013 KPa-1 with regression coefiicient (R2 = 0.92). The third region was beyond 40 
KPa where the pressure sensitivity dropped again to 0.0012 KPa-1 with a good linear relationship 
(R2 = 0.89) (Figure 6-4e). The VOC measured from pressure sensor at four different pressure values 
indicated that the voltage profiles were time dependent (Figure 6-4f). To study stability of the as 
fabricated ferro-TENG pressure sensor, ≈1200 cycles of repeated loading/unloading of 80 kPa 
pressure were applied. Current profile showed only tiny change in the output signal confirmed the 
stability of the pressure sensor performance for long-run under high-frequencies (Figure 6-4g). 
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Figure 6-5. Self-powered magnetic sensor; (a) Photographs of ferro-TENG used as a wearable 
magnetic sensor on the finger and the hand rest compared to flat battery(b) Characterization of the 
magnetic field strength generated from three different magnets with the same diameter at different 
distances. (c) The ferro-TENG short-circuit current signals using magnet-3 with different distance 
between the sensor and the magnet. (d) Relationship between the magnet-3 strength and ferro-
TENG current outputs vs the device distance in cm indicating the behaviour similarity. (e) Short-
circuit current signals of the Effect of magnetic strength on the ferro-TENG outputs. (f) 
Comparison between the magnetic strength of the three magnets with the ferro-TENG short-circuit 
current outputs indicating the slope similarity at 1cm distance. Self-powered rotary magnetic 
sensor; (g) Schematic of the rotary magnetic sensor experimental setup. (h) The plot of current 
profiles as a function of time at different rotation frequencies. (i) The relationship of ISC profile 
frequency against the applied speed for the magnetic TENG sensor. (j) Characterization of the 
output magnetic field strength from the rotary magnetic device in x, y, z, and total direction with 
different speed in rpm. (k) Comparison between the magnetic rotary device output relation with 
different speeds and the ferro-TENG output indicating the slope similarity. 
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    Supported by the magnetic responsive ferrofluid, we proposed a self-powered magnetic, and 
self-powered rotary magnetic ferro-TENG sensor (Figure 6-5). Real photos of ferro-TENG as a 
wearable magnetic senor on finger, and the hand rest, were demonstrated in Figure 6-5a. By 
moving a magnet towards sensor, electrical output was generated, depending on the magnetic 
strength and the distance between the magnet and sensor. Characterization of the three different 
magnets at different distances from the ferro-TENG sensor indicated that the magnet strength 
decreases with increasing distance. (Figure 6-5b). Magnet no.3 showed the highest magnetic flux 
and was selected for further studies where ferro-TENG short-circuits current signals (Isc) was 
decreasing as the sensor moves away from the magnet (Figure 6-5c). Comparison between the 
magnetic flux measured using a gaussmeter and ferro-TENG current outputs as function of device 
distance indicated the behaviour similarity (Figure 6-5d). Short circuit current signals, generated 
from ferro-TENG using different magnets with different strengths a constant distance, were 
measured (Figure 5e) and output current Isc increased with the increase in the magnetic strength. 
In addition, the ferro-TENG output current generated from 3 different magnets at 1 cm distance 
from the sensor was compared to magnetic flux measured at the same distance (Figure 6-5f). Both 
values had slope similarity indicating a good correlation between ferro-TENG response to the 
applied magnetic field strength. 
 
     Another application of the ferro-TENG was the rotary magnetic sensor demonstrated in Figure 
6-5g. The ferro-TENG device was positioned on the top of the magnetic rotary motor. Increasing 
the frequency and magnetic field strength changes the electrical ferro-TENG signals (Figure 6-
5g). Moreover, a 3-channel gaussmeter was used to measure the magnetic strength in the three 
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spatial directions with different rotation speed in order to calibrate the rotary magnetic motor. 
Increase in magnet rotation speed raised the ferro-TENG electrical output frequency and 
magnitude (Figure 6-5h). The correlation between short circuit current profiles frequencies and 
the applied speed was linear as the rotation frequency increased, the current frequency generated 
from magnetic TENG sensor increased as observed in Figure 6-5i. The characterization of the 
magnetic field strength from the rotary magnetic device in x, y, z, and total directions with varying 
speeds (rpm) was performed using the 3d channel-gaussmeter (Figure 6-5j). Good correlation 
between the magnetic flux of the magnetic rotary device at different speeds with the ferro-TENG 
output current signals was observed as indicated by the similarity in slope (Figure 6-5k). 
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Figure 6-6. (a) Shows the ferro-TENG acoustics setup for the sound level sensors. (b) Normalized 
short-circuit currents (ISC) as a function of acoustic frequency with different sound levels of 70, 90 
and 105 dB. (c) Normalized short-circuit current signals as a function of acoustic frequency at 
sound level of 90 dB. (d) The ISC as a function of acoustic levels and frequencies. (e) 
Nanogenerator performance as an active acoustic sensor for sound level measurement with 
increase in the nanogenerator output signals as function of increased sound source level. 
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     To demonstrate the ability to detect and quantify acoustic waves, different signals were created 
using sound waves generator, which produced different sound levels at different frequencies from 
the speaker. This setup was included in an isolated chamber containing the ferro-TENG device 
beneath the speaker. Extirpating the radial direction is prescribed at the outer boundaries of the 
ferro-TENG device to regulate the resonance frequency of the device, consequently placing it as 
an elastic element to be fluctuated under the excitation of acoustic waves (Figure 6-6a). The 
relationship between ferro-TENG normalized output current signals and varying frequencies from 
10 to 200 Hz, generated by sound levels of 70, 90, 105 and 108 dB, was used to estimate the 
resonance frequency. Resonance frequency corresponds to the maximum of normalized short-
circuit currents (ΔI/I0) as function of acoustic frequency showed that the resonance frequency was 
around 60 Hz. Estimated resonance frequencies was consistent with the calculated first mode 
natural frequency of 61 Hz18. The output current of the device induced with a 105 dB sound level 
showed 2 folds increase more than that with the pre-stress of 70 dB. The acoustic frequencies 
ranging from 0 to 200 Hz corresponding to acoustic pressures ranging from 70 dB to 105 dB when 
detected by using sound level meter (Figures 6-6b). At resonant frequency of 50 Hz, the decrease 
in acoustic level from 105 dB to 70 dB is accompanied by decrease in the maximum normalized 
short-circuit current from 0.28 to 0.15, which could explain the sensitivity to noise and its closeness 
to the resonance frequency. Therefore, this ferro-TENG could work in tonal noise environments, 
where it is maintained within the accepted exposure limit (Figure 6-6c). A linear relationship is 
observed when nanogenerator is functioning as an active acoustic sensor for sound level 
assessment explaining that the higher the sound source level, the higher the nanogenerator output 
signals (Figures 6-6(d, e)). 
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Figure 6-7. Soft robotics and underwater sensing applications. (a) The application of ferro-
TENG underwater sensor, inset is the real photo of the soft robotic (scale bar is 5 cm). (b) The 
open circuit voltage profiles plot with different waves from the wave maker. (c-d) The open-circuit 
voltage profiles with different deed rates, explaining the increasing of sensor output. (e-f) The 
electric voltage changes of ferro-TENG sensor as a function of the distance between the sensor 
and the wave source, showing the diminishing behavior with increasing distances. (g) i) illustration 
of the attached ferro-TENG on the finger, ii) Integrating the ferro-TENG with 3D printed robotic 
hand. (h) Measuring the finger angle underwater, indicating the capability of applying the sensor 
as a wearable sensor under water. 
Application of the ferro-TENG device as an underwater sensor was investigated in artificial 
wave environment where different waves with different rates was generated using wave maker. 
We observed that the open-circuit voltage profiles were different with different wave types and 
the fabricated ferro-TENG device could successfully differentiate between different wave motions 
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(Figure 6-7 a, b). The sensor voltage rose from 1 V to 2.5 V when the rate increased from 1 to 4 
m3/h due to the progressive increase in the mechanical vibration energy (Figure 6-7c). The sensor 
voltages change was dependent on the wave feed rates (Figure 6-7d) also, sensor resistance change 
was dependent on the distance of soft robotics sensor from the wave maker (Figure 6-7e). The 
mechanical vibration energy gradually dissolute with the transporting route. As a result, the sensor 
voltage decreased from 3 V to 0.5 V when the distance rose from 5 to 50 mm (Figure 6-7f). Ferro-
TENG was integrated into a 3D printed robotic hand for underwater detection of finger motions. 
The as fabricated robotic hand would detect the motion in 3 joints covered by ferro-TENG tube. 
the micro-cracks on the STPS have showed in the bending area of a robotic finger during bending. 
Ferro-TENG output signal current was dependent on the finger bending angles where ISC values 
increased from 0.5 to 3 pA when bending angle increased from 15˚ to 90˚ (Figure 6-7g, h). 
 
6.5-SUMMARY 
       We proposed a highly stretchable, flexible and waterproof ferro-TENG device capable of 
harvesting mechanical, magnetic and acoustic energies with high efficiency and sensitivity. The 
device composed of a silicone tube that worked as a tribo layer, filled with nanoparticle-based 
ferrofluid that facilitated harvesting magnetic and mechanical energies. The unique design and 
flexible components made the device highly flexible and stretchable reaching approximately 300% 
of its original size. Harvested energy could be translated into output electrical signal that allowed 
the device to be a perfect candidate for wearables and smart textiles. the ferro-TENG device was 
capable of sensing and harvesting the magnetic field produced from rotary magnetic machines and 
successfully estimated their magnetic strength and rotation speed. Furthermore, proposed device 
was utilized in biomechanical movements monitoring. The device waterproof properties allowed 
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its potential application in underwater soft robotics to sense and harvest wave power energy. A 3D 
printed robotic hand equipped with the proposed ferro-TENG sensor was also fabricated and 
examined as underwater finger motion sensor. Ferro-TENG have been utilized to sense the 
different frequencies of sound pressure levels for acoustics sensing applications including hearing 
aids and sound sensing platforms. This multifunctional device with multiple sensing and 
harvesting abilities provided a new platform for ferrofluid based TENG. 
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